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iii. Abstract 
Background: There is a growing expectation that medical patients should be more 
involved in decisions about their health and treatment. However, often decisions about 
treatments are required at times of stress, such as following a diagnosis of cancer. 
Objectives: The purpose of this study was to in vestigate the re lationship between 
distress, emotion regulation and patient participation in treatment decision-making for 
cancer, and whether patient participation affects psychosocia l outcomes 
Method: The study was an observational, longitudinal design. Participants were 26 
patients with cancer, recruited at their initial oncology appointment, who completed a 
questionnaire at the time of their consultati on, a second questionnaire fo llowing their 
consultation and a third at three months follow up. Uni variate analyses were used for 
confirmatory data analysis. 
Results: Participants who took a passive or active role in treatment decision-making had 
significantly higher levels of distress, compared to those who reported shared decision-
making. Higher levels of distress and greater difficulties with emotion regul ati on were 
a lso significantl y associated with participants not attaining their preferred role. No 
significant relationship was found between pa1ticipation in treatment decision-making 
and psycho logical adjustment or satisfaction with the decision made. 
Conclusions: Greater awareness of patients ' emotional well-being, at key points in their 
care pathway, would be valuable, to ensure patients' psychologica l needs are met and to 
avoid detrime ntal consequences fo r their health care. 
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1. CHAPTER ONE: INTRODUCTION 
1.1. Introduction 
The paradigm of health care delivery in the National Health Service is changing. Shifting 
away from a model of paternalism, there is a growing expectation that patients should be 
more involved in, and take greater responsibility for, their health and treatment (Scottish 
Executive, 2003). In a policy briefing for the World Health Organisation, Coulter et al. 
(2008) highlight that, alongside improving patients' health literacy and self-management 
skills, promoting participation in treatment decision-making is key to achieving greater 
patient involvement. Models of health behaviour have long theorised that greater patient 
involvement can lead to improved medical and psychosocial outcomes (Bennett, 2000). 
The process of making decisions about medical treatments, however, is becoming 
increasingly complex. With increasing treatment options for many health conditions, 
there is sometimes no si ngle best treatment, rather manifold alternatives with differing 
risks and benefits. Choosing cancer treatments is a case in point. Often described as the 
most feared of modern diseases (Clarke & Everest, 2006), decisions about treatments for 
cancer are often required immediately following diagnosis, when the patient may be in 
the initial stages of psychological adjustment, that is experiencing their early emotional, 
cognitive and behavioural response to the changed circumstances. The rhetoric used in 
treatment decision-making consultations can be inhibiting, and, for the most part, 
patients lack expert knowledge on the subject about which they are being asked to make 
an in formed choice. Research from the cancer literature has shown that not all patients 
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wish to be active participants in the process (Degner & Sloan, 1992). Furthermore, there 
is also a growing understanding that normative, or rational models of decision-making 
are insufficient to account for human behaviour, especiall y at times of stress (Tversky & 
Kahneman, 1981). 
When woven together, these different strands of research pose questions about how we 
can negotiate the facil itation of greater patient participation in treatment decision-making 
for cancer care. Coulter et al. (2008, p.3) recommend that strategies to promote patient 
participation should be a "plank of health policy". In order to develop such strategies, it 
is necessary to understand the challenges faced by patients at the time of making 
treatment decisions, and factors that may assist or hinder their participation. This 
exploratory study focuses on decision-making following a diagnosis of cancer and 
specifically investigates the association of a patient's distress with their participation in 
treatment decision-making. 
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1.2. Putting cancer in context 
Cancer is the third most common type of disease in the western world. Approximately 
30 thousand people are diagnosed with cancer every year in Scotland, and this fi gure is 
expected to increase over the next five years, partly due to the ageing population 
(Scottish Government, 2008). Cancer is a complex group of diseases, wi th over 200 
different types already identified. It is caused by the reproducti on of damaged cells 
within a specific organ or type of tissue, to form an accumulation or mass of damaged 
cells. The most common types of cancers, for men, are cancers of the lung, prostate and 
large bowel, accounting for 53% of cases. For women, the most common types of cancer 
are breast, lung and large bowel, accounting for 55% of cases. 
Improved detection rates and increasing options for treatment are leading to an 
improvement in the fi ve year survival rate for the majority of cancer types. As medical 
care advances, recent policy has highlighted new challenges for health care providers. 
Firstl y, to improve the psychological and social care for people affected by the disease. 
Secondly, in Jjne with the changing paradigm of health care, there is a pressure to make 
care more patient-centred and encourage greater patient participation; for example, a 
consultation respondent for the recent Better Cancer Care document called for patients to 
"be an 'acti ve participant' and not a ·passive pyj ama' patient" (Scottish Government, 
2008, p72). This section outlines these challenges in more detai l, by describing the 
psychological needs of people diagnosed with cancer, and the current guidelines for 
treatment decision-making. 
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1.2.1. The psychological impact of cancer 
Being diagnosed with cancer is not a discrete event; from the first detection of a 
concerning symptom, a catalogue of physical, emotional and social stresses is set in 
motion. Investigations, diagnosis, treatment, recovery and relapse each present 
challenges to the patient. Psychological adjustment to cancer can be prolonged: there are 
high levels of distress and an increased prevalence of psychopathology (Brennan, 2001). 
Successful psychological adjustment can be defi ned as enabling "the successful 
performance of adaptive tasks ... the absence of psychological disorders, the presence o f 
low negative affect and high positi ve affect, adequate functional (e.g. work) status, and 
the satisfaction and well-being in various l.ife domains" (de Ridder et al., 2008, p. 
246)Research has consistently shown, however, that between 28 and 47% of people 
diagnosed with cancer experience clin ically significant levels of psychological distress 
(e.g. Carlson et al., 2004; Zabora et al., 2001 ). The National Comprehensive Cancer 
Network (2008, DIS-3) define distress as "a mul.tifactoria l unpleasant emotional 
experience of a psychological (cogniti ve, behavioural, emotional), social and/ or spiritual 
nature that may interfe re with the ability to cope effectively ... Distress extends along a 
continuum. ranging from common normal feeli ngs of vulnerability, sadness and fears to 
problems that can become disabling, such as depression, anxiety, panic . .. ". A large 
survey of 4496 cancer patients, at various stages of their treatment, found that 35% of 
patients were suffering fro m c linical levels of distress, with the most common 
diffi culties reported including adjustment disorder, depression, and anxiety (Zabora er 
a/. , 200 I ). Studies that have used a longitudina l methodology have fo und that distress 
levels fo r cancer patients can remain elevated from diagnosis through to the e nd of 
treatment (Northouse et al., 199 1 ). 
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Elevated levels of distress through the care pathway, is consistent with a diagnosis of 
cancer initi ating a series of adverse events for the patient. Monitoring patient distress 
through the care pathway is now advocated in current guidance for the supportive care of 
adults with cancer. The National Institute of Health and Clinical Excellence (2002) states 
that assessment and discussion of patients' psychological needs should be undertaken at 
key times in the care pathway. However, although psychological research has produced 
evidence of the efficacy of formal psychological interventions, in addressing specific 
psychological problems, there is less research addressing how to best meet psychological 
needs within the usual system of medical care. 
One approach to understanding how to meet psychological needs is to investigate the 
impact of physical and situational stressors, associated with different stages of the cancer 
treatment pathway, on a person's emotional well-being. Armitage er al. (1999) point out 
that, in turn, a person 's emotional well-being can influence how they cope with further 
stressors, thereby potentially creating a spiraling negative trajectory, and having a 
compounding influence on a person's health and psychosocial outcomes. There may be a 
relatively complex interplay between stressors, a patient's distress and coping and their 
consequent physical and emotional well-being. The current study focuses on this 
interplay at the time of making treatment decisions fo llowing a recent diagnosis of 
cancer. 
Being delivered a diagnosis of cancer has been likened to suffering a trauma: "a sudden 
unexpected life threatening event over which there is little personal control" (Brennan & 
Moynihan, 2005, p.17). In their seminal paper, Weisman and Worden (1976) described 
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the ignificance of the first 100 days in ' the existential plight' that follow a diagnosis of 
cancer. Thei r study found that the first 100 days following diagnosis were characterised 
by high di tress, and specific concerns about survival and phy ical well-being, but 
crucially that well-being at this time was predictive of a person 's long-term 
psychological adjustment. A lthough Weisman and Worden's time frame may have been 
somewhat arbitrary, their study suggests that psychologically sensiti ve care, in the period 
immediately following diagnosis, may be able to contribute to successfully guiding a 
person's long-term psychological adjustment to their illness. 
During the initial period of adjustment, a patient faces several challenge , including key 
decisions about medical treatments. The successfu l negotiation of treatment decision-
making is vital, in order that the patients can provide informed con ent and commence 
the treatment quickly. However. research has shown that not all patients are successfully 
negotiating this challenge. Montgomery eta/. ( 1999) interviewed I 00 patients attending 
a radiotherapy clinic. One fifth of their participants did not recall having signed a 
consent form, even though all of them had, and almost a qua1ter could not recall any side 
effects of the treatment they had strut ed. Pa1ticipants who scored above the clinical cut-
off for anxiety and depression were significantly more likely to report that they were less 
happy with the information they recei ved, and wanted more information about both 
cancer and their treatment. 
In keeping with the earlier point about the interdependence of illne s related stressors 
and patient ' emotional well-being, the authors suggest that patients who were 
p ychologically distressed were perhaps less able to take on available information, and 
therefore more likely to report dissatisfaction as a resu lt. As such, understanding the 
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potential effect that a person's distress can have during treatment decision-making will 
be important so that health care professionals can best support patients to negotiate these 
challenges successfully, and guide them towards a trajectory of positive psychological 
adjustment. 
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1.2.2. Current practice for treatment decisions for cancer 
The majority of people with cancer will be treated using one, or a combination, of 
surgical intervention; radiotherapy; chemotherapy and hormone therapy. The treatment 
options will depend on the type and stage of the cancer; whether it has affected the 
lymphatic system; and whether the cancer has metastasised or spread. 
The current government target in Scotland is that a ll primary cancers will be treated 
within 62 days of the patient's first presentation or referral to the cancer services. Within 
this time period a person must undergo investigations to diagnose and stage their illness 
and commence treatment. Even if the fLrst 100 days, described by Weisman and Worden 
(1976) are an arbitrary time frame, this highlights that these first 62 days are a time of 
heightened distress and a person's experience at this time may have a substantial 
influence on their long-term psychological adjustment. 
Prior to an oncology treatment decision-making consultation, the majority of decisions 
about a patient's treatment are discussed at a multi-disciplinary meeting, as advised by 
the Scottish Intercollegiate Guidelines Network (SIGN, 2003, 2005a, 2005b 2006). 
Patients do not ordinarily attend these meetings, however, all the guidelines advocate 
that patients are fully informed about decisions that are made. Some, although not all, of 
the specific cancer site guidelines explicitly state that patients should be involved in the 
decision-making process, if they so wish (NICE, 2002; SIGN 2003, 2005a). However, 
contrary to the recommendation made by Coulter et al. (2008), that strategies to support 
patient participation should be a "plank of health policy", the guidelines do not expound 
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on the practicalities of how to promote participation or how to address any potentia] 
impediments. 
As previously discussed, it is likely that patients diagno ed with cancer will be suffering 
high rates of distress at the time of the treatment decision, which is the focus of this 
study. All the guidelines do advise that clinicians shou ld be aware of patients' emotional 
well-being at all stages, with the guideline for the management of colorectal cancer 
specifically citing a research paper that found patients describe particular distress while 
waiting to see the Oncologist (Knowles et al., 1999). However, none of the guide lines 
presents evidence on how high levels of distress may affect patients' interactions with 
the health care system, or provide specific guidance on the best management of this; in 
fact, many guidelines comment on the lack of evidence of how to best manage this. 
1.2.3. Section summary 
Cancer is one of the most common modern diseases. Improvements in medical outcomes 
have led to a greater awareness of the psychologica l impact of being diagnosed with 
cancer, and attention is turning towards the interplay between patients' emotional well-
being, their engagement with health care services, and their longer-term psychological 
adjustment. While the extent of the psychological need in people diagnosed with cancer 
is well established. the impact and management of distress at key stages of the diagnosis 
and treatment process, such as treatment decision-making, remain under researched. 
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l.3. Understanding the context of patient participation in treatment decision-
making 
A recently as the 1960s, patients were not routinely informed that they had been 
diagnosed with cancer. This has dramatically changed, with patients increasingly being 
seen as acti ve participants in their health care. This section outlines the development of 
the current theoretical ideal for patient participation in treatment decision-making. 
1.3.1. Factors leading to increased patient participation in their health care 
The shift in attitude, toward considering patients as acti ve partners in their health care, 
can be understood as a product of medical, social and politkal changes. From a political 
perspective, there is an increasing focus on the ethical concern that people have the right 
to be con idered as autonomous beings (Weinfurt, 2003). Giving informed consent is 
now recognised as a universal right for patients; this process in itself inherently requires 
acti ve participation. 
From a medical perspective, scientific advances have created a greater number of options 
for treatments and, simultaneously, patients are becoming progressi vely more informed 
about their own health due to the exponential growth in media technology. The correct 
choice for treatment is often not clear-cut, and becomes a maner of preference by the 
medical team or patient. There is also a changing pattern of physical health problems. 
with people facing less acute disease. but a greater number li ving with longer-terrn 
conditions. A s such, increasing value is now being placed by patients on psycho-social 
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outcomes, such as quality of life, in addition to, or someti mes even at the expense of, 
more traditiona l medical outcomes, such as survival rates (Wei nfurt, 2003). 
The increasing prevalence of the view that patients should be involved in their health 
care is illustrated by the change in the dominant, or favoured, model of treatment 
decision-making. While acknowledging that different decision-making styles may be 
suitable in different settings, recent work atte mpting to clarify best practice in invo lving 
patients in decision-making has focused on the model of shared decision-making, 
described by Cathy Charles and colleagues (Charles et al., 1997; Charles et al. , 1999) 
1.3.2. From the paternalistic to the shared treatment decision model 
Previously, the dominant model of delivering health care was one of paternalism, with 
doctors assuming the dominant role (Table 1 ). Underlying this model were four basic 
tenets: first, that the majority of illnesses had a definite best treatment; second, that 
doctors knew the best treatment for the patient; third, that doctors were best placed to 
evaluate any decisions if there was a choice in treatment; and fourth , that doctors were 
professionally bound to act in the best interest of the patient (Charles et al., 1999). 
Patients adopted a passive role in any decision-making process, akin to Parsons' (1951 ) 
depiction of a 'sick role', in which he describes that the sick have an obligation to seek 
help, and comply with medical treatment. I t is evident that this autocratic style of health 
care delivery, for the majority of treatment contexts, is becoming increasi ngly less 
credible in the current social climate. In reaction to the prevalent paternalistic model 
therefore, the in formed decision-making model was developed. 
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The informed decision-making model (Table I) recognises that the patient participation 
in making decisions, within the paternalistic model, is inhi bited by the patients' Jack of 
knowledge. Embracing the concept, that patients should now be held as active 
participants in their health care, the model focuses on the doctor communicating all the 
technical and scientific knowledge to the patient, in order to allow the patient to 
deliberate and make the decision (Emanuel & Emanuel, 1992). However, this model has 
also been heavily criticised. 
Patcrnnllstic Shared decision Informed model 
model making model 
Flow One way Two way One way 
Direction Doctor to patient 
Doctor to patient 
Doctor to patient 







Minimum legally All relevant for AU relevant for 
required decision-making decision-making 
Doctor alone, or 
Doctor and patient 
Patient (possibly 
DdilJt!ratiun with other doctors (possibly with with others) 
others) 
Decision about 
implementing Doctor Doctor and patient Patient 
treatment 
Table 1: Models of treatment decision-making from Char les et al. (1999, p. 693) 
The model effectively reduces the doctor's role to providing information and disregards 
their technical expertise. Research has found that a patient reporting a desire for 
information is not equivalent to their wanting to participate in the decision-making 
process (Cassi leth et a/. , 1980). In addition , research has found that simpl y imparting 
knowledge about a treatment may not be sufficient to enable the patient to make an 
informed decision. For example, Chapman et al. (2003) evaluated the level of 
understanding, in lay people, of key terms used in an oncology consultation. The level of 
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understanding was very poor, with just over hal f of the participants understanding 
euphemisms for the progression of the cancer. At a more basic level, 94% of the sample 
were able to identify the location of the lungs in the body correctly, but only 46% were 
able to identify the liver accurately. Hurley er al. ( 1992) explain that, in fact, the 
asymmetry of knowledge in treatment decision-making affects both the doctor and the 
patient. While the doctor possesses better knowledge of the effecti veness of certain 
treatments, the patient possesses better knowledge about their well-being and quality of 
life: both sets of knowledge need to be combined for an effecti ve treatment decision to 
be made. 
This led to Charles er at. (1997) outlining the model of shared decision-making (Table 
I ). At a minimum this model requires that both doctor and patient are involved in the 
treatment decision-making process, both share information with each other, both express 
treatment preferences and, in due course, a treatment decision is made by both the doctor 
and the patient. Shared decision-making ultimately balances doctors· expertise with 
patients' preferences, to achieve informed and high quality decisions. The model now 
dominates the rhetoric of research and policy in decision-making. Its description of the 
idea l characteristics of the doctor-patient rel ationship clarifies the concept of shared 
decision-making, and therefore provides guidance for ideal clinica l practice. 
The model does not, however, address some of the more specific processes that may 
impact on achieving shared decision-making. In order to participate in the decision-
making process patients have to appreciate complex information; understand and 
interpret information about probabilities; and form and express their own preferences 
(Entwhistle & Watt, 2006). Treatment decisions often occur at times of stress, which is 
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known to affect the quality of a person's information processing. Therefore, in order to 
faci litate not just greater patient participation, but valid patient participation, it is 
necessary to begin to understand the processes of patients participating in treatment 
decision-making, what facilitates it and what hinders it. These specific processes are 
discussed further in section 1.6. 
1.3.3. Section summary 
Patient participation in treatment decision-makjng is increasingly being regarded as 
preferred practice. Previously doctors adopted a paternalistic role, making, and taking 
responsibility for, all health care decisions; however, changes in social, ethical and legal 
views, have led to this style of health care delivery being overturned. Debate has ensued 
about the best model of practice, with some authors theorising that patients could 
potentially take the active role in treatment decision-making, if provided with sufficient 
information. However, research has shown that in practice this may not be possible, or 
preferable to patients, and the majority of recent research has promoted a model of 
shared decision-making as best practice (Charles et al., 1997). 
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1.4. Patient participation in treatment decision-making 
The Shared Decision-making Model is recommended as the best theoretical mode l of 
practice, however, research in a naturalistic clinical setting has not found that it is either 
unilaterally prefen ed by patients, or the prevalent style of decision-ma king used in 
consultations. Thi s section describes research looking at patient preferences for, and 
actual, participation in treatment decision-making for cancer. 
1.4.1. Patient preferences for participation in treatment decision-making 
Patterns of patient preferences for participating in treatment decisions fo r cancer vary 
widely in published studies. The majOiity of studies have used the Control Pre ference 
Card Sort (Degner & Sloan, 1992), or the statements by Sutherland et al. (1989), to 
categorise patients into preferring one of three roles in the process of treatment decision-
making: pass ive, acti ve or shared. The three roles mirror the di fferent paradi gms of 
health care deli very described early, the paternalis tic. in formed and shared decision-
making models. In order to summari se the available research, the resu lts o f 28 studies 
which used the Control Preferences Card Sort, decision preference sta te ments or si milar 
c lassifications are summari sed in Figure I. 
It is immediate ly apparent that patients vary in the degree that they want to be involved 
in decisions about their treatment; however, trends are evident. The majority of studies 
(24/28) report that less than 30% of patients prefer an active ro le in decision-making. 
Almost all the studies (27/28) show that over 20% of patients prefer a collaborative or 
shared role in decision-making. However, the proportion of patients preferring a passive 
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role varies from less than 10% to over 60%. This is in stark contrast to the shift towards 
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Figure 1: Summary of studies of percentage of patients preferring active, shared or passive role 
in treatment decision-making (Included studies: Beaver & Booth, 2007; Beaver et al.., 1996; 
Bilodeau & Degner, 1996; Bruera et al. , 2002; Butow et al. 1997; Davison & Degner, 1997; Davison 
et at., 2004; Degner & Sloan, 1992; Degner et al., 1997; Elkin et al., 2007; Hack & Degner, 1999: 
Hack et al. , 1994: Jansen et at. , 2006; Janz et al. , 2004; Kraetschmar et at., 2004; Lam et al. , 2003; 
Lobb et a/. , 2003; Ong et al., 1999: Ramfelt et al., 2000; Ramfelt et at., 2005; Rothenbacher et al., 
1997; Salkel.d et al. , 2004; Stewa1t et al., 2000; Stiggelbout & Kiebert, 1997; Sutherland et al. , 1989; 
Vogel et al. , 2008; Wallberg eta/. , 2000; Wong et al., 2000) 
The studies do differ in their quality and methodology; for example, the sample sizes of 
the studies vary widely. Ramfelt et al. (2005) found that 1.8% of their sample of 55 
patients diagnosed with colorectal cancer would prefer an acti ve role in the treatment 
decision-making process, which equates to onl y one participant, limiting any conclusions 
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that can be drawn; however, even studies with a greater number of participants have not 
provided consistent results (Degner & Sloan, 1992; Jan en et at., 2006; Kraetschmar et 
at., 2004). A survey of 436 cancer patients found 12% of people preferred an active role 
in decision-making; 29% a shared role and 59% a passive role (Degner & Sloan, 1992). 
However, another study of 446 cancer patients found that twice as many people 
prefen·ed an active role in decision-making; and half as many a passive role (Jansen et 
at., 2006). 
1.4.2. Stability of patient preferences 
The inconsistency of findings suggests that there are variables influencing patient 
preferences that differ between studies. One methodological inconsistency between 
studies is the point of a person's illness or treatment at which they were surveyed. For 
example, Davison et at. (2004) asked their participants their preferences for participation 
at the time of diagnosis, whereas some of the participants in the study by Degner et at. 
( 1997) were over 30 years post-diagnosis. A study by Butow et at. ( I 997) found that the 
majority of their 80 participants changed their preferences for participation between their 
baseline and follow up measurement, with a trend toward wanting greater participation. 
This suggests that patients' prefe rences for participation in decision-making are 
changeable. 
In a larger study. with 729 participants, Mallinger et at. (2006) a lso found changes in 
patients' preferences for participating, from before their treatment until its completion. 
While the majority of patients who initially preferred a passive role maintained this 
preference, overall , 37% of patients wanted to be less active and 22% wanted to be more 
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active. A multivariate analysis of factors associated with a patient's preference for 
participation in treatment decision-making following the end of their treatment found 
that onl y 16% of the variance was explained by previously expressed preferences and 
socio-demographic variables. Malinger et a/. (2006) suggested that a patient's 
preferences for participation are not static, but rather influenced by dynamic factors , 
related to their clinical, psychological and social conditions. For example, from the point 
of diagnosis, the patient will learn more about the illness they must make decisions 
about; start to adjust psychologically; and bui ld a relationship with the medical team 
eating for them. All of these factors may influence the role a patient wishes to take in 
treatment decision-making; unfortunately, key decisions about treatment are often made 
before these factor have had time to deve lop. 
1.4.3. Actual participation in decision-making 
Studies looking at patients' actual role in treatment decision-making for cancer again 
report varying trends. Estimates of the propottion of patients taking a passive role range 
from 8% to 77%, and similarly the proportion of patients taking an active role ranges 
from 7% to 62% (Janz er a/., 2004; Ramfe lt et al., 2000). The proportion of patients 
reporting a shared treatment decision ranges from 13% to 30% (Fischer et al., 2006; 
Vogeler at., 2008). 
Table 2 summarises quantitative studies that have investigated whether patients have 
attained their preferred role. Again, finding vary widely, different tudies report that 
patients take their preferred role in treatment decision-making in between 34% and 80% 
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of cases (Gatellari et al. , 2001; Wallberg et al., 2000); no studies found complete 
concordance. 
Attained More active More passive 
Study Patient population preferred than preferred than preferred 
roiP (%) {% ) (%) 
Gatellari et 233 heterogeneous 
34% 29% 37% al. (2001) cancer patients 
Beaver et al. 150 breast cancer 
38% 22% 39% ( 1999) patients 
Degner et J 012 breast cancer 42% n/a n/a al. (1997) patients 
Janz et al. 99 breast cancer 
42% 39% 18% (2004) patients 
Ramfelt et 85 colorectal 
44% 8% 48% at. (2000) patients 
Keating et 1 081 breast cancer 
49% 26% 25% at. (2002) patients 
Bilodeau & 
74 breast cancer 
Degner 
patients 
50% n/a n/a 
( 1996) 
Beaver et al. 48 colorectal 
60% 18% 22% (1999) cancer patients 
Vogel et al. 137 breast cancer 63% 15% 22% (2008) patients 
Beaver & 
53 gynaecological 
Booth 66% 11% 23% 
(2007) 
cancer patients 
Hawley et 1038 breast cancer 66% 2 1% 13% 
al. (2007) patients 
Davidson et 21 lung cancer 
71% 0% 29% at. (1999) patients 
Wallberg et 20 I breast cancer 
72% 8% 20% at. (2000) patients 
Lam et at. 154 breast cancer 
80% 13% 7% (2003) patients 
Table 2: Summary of studies investigating concordance between patients ' preferred and actual 
roles in treatment decision-making 
For the majority of studies, patients were more likely to repo1t taking a more passive role 
in decision-making than they would have preferred. For example, in their study with 85 
colorectal patients, Ramfelt et at. (2000) found that nearly half of their participants were 
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more passive in decision-making than they would have preferred. Furthermore, Vogel er 
al. (2008) found that patients who preferred a distinct active or passive role were 
significantly more likely to achieve this, compared to tho e who preferred a shared role. 
As shared decision-making has been promoted as best practice within the evidence base 
(Charles et a!., 1997), the discrepancy between preferred and actual roles leads to the 
question of what factors are influencing patients' level of participation in treatment 
decision-making consultations. The studies which have investigated concordance shows 
that the studies all differed in the age and gender of participants included, and the type of 
cancer participants had been diagnosed with; however they do not reveal any immediate 
obvious stark demographic trends in rates of concordance. 
1.4.4. Section summary 
A synthesis of published studies highlights the variability in patient preferences for 
participation in treatment decision-making. A signifi cant proportion of patients with 
cancer express that they would not wish to be involved in treatment decision, and studies 
report that less than a third of participants are sharing decisions with their doctors. This 
is an evident disparity with the dominant shared decision-making model. 
Furthermore, studies have consi stently found that patients do not always achieve their 
preferred level of participati on in treatment decision-making, suggesting that a patient's 
preferences is only one variable that will influence their level of participation in 
treatment decisions. The evidence for other variables in fluencing patient participation in 
treatment decision-making is discussed further in sections 1.6 and 1.7. 
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1.5. Psychosocial outcomes related to patient participation in treatment 
decision-making 
Despite the shift toward a shared decision-mak1ng model, less than one third of patients 
report sha1ing treatment decisions with their doctors. Further, a significant proportion of 
patients describe being more passive that they would have preferred. In order to 
understand the implication of this disparity, it is useful to consider the outcomes 
associated with pat1ent participation in treatment decision-making. 
There is a growing assumption that traditi.onal clinical outcomes, such as survival rates, 
are enhanced by considering psycho-social outcomes as well , with patients placing an 
increasingly high value on outcomes such as social functioning (Weinfmt, 2003). This 
section considers the research into the impact of patient participation in treatment 
decisi.ons on patients' social functioning and emotional well-being. 
1.5.1. Knowledge about treatment options 
Cancer treatment methods are often described using complex medical terminology, and 
choosing between treatments may involve weighing up potential risks and benefits. As 
previously discussed, many lay people find thi s level of medical knowledge hard to 
understand (Chapman et al., 2003). However, in order for patients to give informed 
consent for their medical treatment, it is necessary that they are aware of the implications 
of any decisions. Greater patient participation in the decision-making process has been 
found to be associated with the patient having increased knowledge about the illness and 
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treatment, suggesting a more ethical decision-making process (Fagerlin et a/., 2006; 
Gatellari et a/., 1999) 
Gate llari et a/. ( 1999) investigated the recall of important in fo rmation about treatment 
decisions in 11 8 patients with incurable disease two week after they had attended the 
oncology c linic for the first time. Greater encouragement of participation by the clinician 
was found to be associated with greater recall of information by the patients (Gate llari et 
al. , 1999). Tn a larger study, Fager! in et al. (2006) surveyed 1844 breast cance r patients, 
who had either had breast conservation surgery or mastectomy, an average of 8 months 
after their diagnosis. Despite rating ' recurrence rates' and 'survi val rates' as important 
factors in their treatment decision-making, Jess than half the women, accurately knew 
what these were, or the difference in these rates for the two treatment choices. 
Multi variate analysis, controlling for demographic and illness variables, showed that the 
women's level o f understanding was positi vely associated with whether they reported 
surgeons had explained the different treatments to them. In keeping with Gate llari et a/. 's 
( 1999) finding, this illustrates the central importance of patient participation in 
consultati ons for increasing knowledge about treatment options. 
Of note, and particular relevance to the current study, Fagerlin et a/. (2006) suggests that 
low literacy; poor access to information; insufficient time to make a decision; and patient 
anxiety may all have detrimental effect on the level of a patient's understanding, with 
one in three of the study's participants reporting that fea r inhibited their decision-making 
ability. 
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1.5.2. Psychological adjustment 
The most widely researched outcome of patient participation in deci ion-making is hort 
and long-term psychological adjustment. M orris and Royle ( 1988) studied 30 breast 
cancer patients to examine whether having a choice of type of surgery, between either 
mastectomy or breast conservation surgery, affected their levels of anxiety and 
depression. The patients who were not offered a choice were found to have higher levels 
of anxiety and depression before and after surgery, which remained elevated two months 
later. This preliminary study has been criticised however, as patients were not randomly 
assigned to one of the two comparison groups, rather the groups were dictated by 
whether a choice in type of surgery was feasible given the i llness characteristics. This 
may have resulted in group specific variables, such as patient percei ving their illness as 
more seri ous when they were not offered a choice, which may have naturally led to 
heightened distress. 
Deadman et al. (200 I ) compared the psychological adjustment of 114 patients divided 
into three groups: one group required compulsory mastectomy; one group's treatment 
was elected by the surgeon and one group elected the treatment themsel ves. In this 
study, patients were randomly assigned to one of the latter two groups where a choice of 
treatment was possible. Overall, patients who elected their own treatment had 
signi ficantly better psychological adj ustment, suggesting that increased participation in 
decision-making does lead to i mproved emotional well-being. While this study is a 
valuable contribution to the evidence base, tudies using this methodology are 
increasingly di fficult f rom an ethical perspecti ve, as patient choice becomes increasingly 
recommended by policy. 
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Fallowfield et ai. (1994) carried out a three year prospective study of the impact of 
participating in surgical decision-maJdng for 269 cancer patients. The patients attended 
one of 22 surgeons who preferred mastectomy; prefen·ed breast conservation surgery; or 
offered a choice where possible. The patients attending surgeons who offered a choice 
where possible had the lowest incidence of distress over a three year fo llow up period. 
However, further investigation found that, within this group, just over half genuinely had 
a choice to make, whereas the other patients' treatment was determined by clinical 
factors. There was no difference in the rate of distress between these groups, which led 
the researchers to conclude that, rather than the availability of treatment options, the 
doctor's consultation style was key in detennining patients' psychological well-being. 
There is consistent evidence that patients do not have a universal preference for their 
level of participation in decision-making (Degner & Sloan, 1992). This has led some 
researchers to investigate whether it is simpl y participating or participating the preferred 
amount in the decision-making process that l.eads to improved psychological adjustment. 
Hack et al. ( 1994) found that breast cancer patients who prefer a more passive role found 
pressure to be active in the decision-maJd ng process very anxiety provoking. Gatellari et 
al. (2001) assessed patients' preferences for pat1icipation in their treatment decisions 
prior to attending their initial oncology appointment, and then compared this to their 
actual experience. Only one third of their 233 participants attained the level of 
participation that they had wanted. A mismatch of roles was found to be significantly 
associated with higher anxiety levels immediately post-consultation, but the level of 
anxiety at two weeks fo llow up was not different between the two groups. Therefore, 
there is evidence that patient participation in treatment decision-making can lead to 
better psychological adjustment; however, this may be dependent on a patient' s desire 
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for participation. Indeed, where patients feel forced to become involved there may be a 
deleteriou impact on their psychological well-being. 
1.5.3. Quality of life 
Research has also investigated the impact of a person's participation in making treatment 
decisions on their functioning and quality of life. Street and Voigt (1997) followed up 
51 breast cancer patients 12 months after their initial surgical consultation. The patients 
who had acti vely participated in thei r consultation reported a higher health related 
quality of life and a greater feeling of responsibility for their treatment decisions. 
Similarly, a larger scale study followed up 205 breast cancer patients, three years after 
their initial treatment decision, to assess their quality of life and functioning (Hack et al., 
2006). Patients who had acti vely participated reported a significantly higher quality of 
life, specifically for physical and social functioning compared to patients who had 
reported a shared or passive role in decision-making. Emotional, role and cognitive 
functioning were not significantly different between the groups. 
Both the studies indicated that greater participation is associated with an improved 
quality of life. The findings of both studies, however, require caution as, despite Hack et 
a!. (2006) finding that several socio-demographic characteristic were significantl y 
as ociated with participants' quality of life, these were not considered in the analyses. 
This was similarly the case in Street and Voigt's (1997) study. In conclu ion, therefore, 
further consolidating research is required about the relation hip between patient 
participation in treatment decision-making and quality of life. 
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1.5.4. Satisfaction with decision 
Finally, research has also studied the relationship between patient participation in 
treatment decision-making and their satisfaction with the dec ision made. Fischer er al. 
(2006) found that prostate cancer patients involved in decisions about their medical care 
had higher satisfaction with their treatment decisions and that this level of satisfaction 
was not associated with their level of distress or quality of life. 
However, in line with the argument that patients should be encouraged to take their 
prefe rred role, research has found that satisfaction with health care is highest for patients 
whose participation in their treatment decisions is in concordance with their preferences. 
A large study of I 081 women with early stage breast cancer showed that, approximately 
three months after surgery, those who attained their preferred role in decision-making 
were more li ke ly be satisfied with the decision-making process, when patient, surgeon 
and hospital characteristics were contro lled for (Keati ng eta/. , 2002). 
Just as satisfaction has been associated with patient participation in decision-making, 
research has found that being unable to participate in decision-making can result in 
regret. A survey of 123 women approximately one year after di agnosis found that while 
over half experienced no regret over their treatment decisions, a sizeable minority 
( 19.5%) experienced moderate to strong regret (Sheehan er a/ .. 2007). Lantz et al. (2005) 
found that, while patients whose preference for participation in decision-making is met 
are more satisfied with their care, patients who have more or les participation than 
prefe rred show more ambivalence about their decisions, or regret. 
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1.5.5. Section summary 
Overall research has found that patient participation in treatment decision-making is 
associated with improved outcomes, including better psychological well-being, increased 
satisfaction, decreased regret, increased knowledge and improved quality of life. 
However. there is some evidence that this association is not simple, and in some 
instances, rather than absolute patient participation, a patient participating to the degree 
that they prefer, may be key in improving outcomes. This leaves a somewhat ambiguous 
picture. Given the paradigmatic shift toward increased patient participation, it will be 
important for the ongoing research to resolve the conundrum of whether universally 
promoting patient participation, or enabling patients to achieve their preferred level of 
participation, leads to improved outcomes, and indeed whether at times participation can 
be deleterious. In either instance, further understanding of factors that influence patient 
participation in treatment decision-making is necessary. Understanding what fac ilitates 
and hinders the process of a patient participating in decision-making wi ll provide a 
guiding framework by which to improve patient care . 
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1.6. Understanding the process of participating in treatment decision-making 
Research has shown that patients with cancer do not a lways attain their preferred level of 
participation in treatment decision-making. The massive variabi lity in concordance 
between patients' preferences and actual role in treatment decision-making between 
studies (section 1.4) illustrates that static demographic factors, patient preferences and 
cancer type, may be insufficient to explain what influences patient participation. This 
section explores processes that may contribute to patient participation in treatment 
decision-making from a theoretical perspective. 
1.6.1. Theory of Planned Behaviour 
One of the dominant models used to understand human behaviour in a health context is 
the Theory of Planned Behaviour (Ajzen, 1988), an extension of the Theory of Reasoned 
Action (Ajzen & Fishbein, 1980). The Theory of Reasoned Action predicted that 
behaviour can be determined by a person 's intention to carry it out. A person's intentions 
are shaped by their attitudes, that is their beliefs about the behaviour and its potential 
outcome; and subjective norms, that is the person's perceptions about other people's 
be liefs about the behaviour. The Theory of Reasoned Action, however, was criticised for 
being limited to explaining behaviours which were solely dependent on personal agency; 
it was argued that regardless of the strength of a person ' s intention to carry out a 
behaviour, inevitably behaviour is partially determined by personal and environmental 
barriers (Armitage & Connor, 2000). Therefore, the Theory of Planned Behaviour added 
an additional factor to the model of behaviour: perceived behavioural contro l. Perceived 
behavioural control indexes a person ' s perception of their ability to perform the 
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behaviour and has variou ly been described as indexing a person's internal resources, 
their . elf-efficacy and their locu of control (Am1itage & Chri tian, 2003). 
For the most part re earch into the Theory of Planned Behaviour ha focu ed on 
volitional health promotion behaviour; however, it is useful to consider it here to 
understand the process of patient participation in treatment decision-making 
consultations for two reasons. Firstly, the research into patient participation shows that 
patient preferences for participation do not concord with their actual decision-making 
behaviour. In parallel, the Theory of Planned Behaviour has found that intention to 
perform behaviour does not always result in it being implemented. A recent meta-
analysis of 185 studies found that the Theory of Planned Behaviour accounted for 27% 
of variance in ub equent behaviour (Armitage & Connor, 200 I ); while 27% is a 
ub. tantial proportion, it leaves 73% unaccounted for. namely the intention to action 
gap. 
The theory has been praised for its economy; it requires only a few factors to account for 
significant variance in behaviour (Abraham & Sheeran, 2003); however, the opposing 
view is that its parsimony leads to the exc lusion of key factors. A criticism levelled at 
the Theory of Planned Behaviour is that it relies too heavily on rational decision-making 
proce ses by the individual (Armitage er a! .. 1999; Ingham, 1994); one of the most 
significant variables that authors contend is absent from the Theory of Planned 
Behaviour is the influence of a person's emotion (Armitage era! .. 1999). Therefore the 
second reason that the Theory of Planned Behaviour i important to consider. when 
understanding the process of patient participation in treatment decision-making 
consultations. is that it is the main contention of the current study that emotion can 
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significantly impact on the implementation of the prefened role in treatment decision-
making. 
The addition of perceived behavioural control to the Theory of Planned Behaviour 
acknowledges that there are personal and environmental barriers which may directly 
affect whether a behaviour is carried out. Indeed, Armitage and Connor (200 1) 
established that perceived behavioural control directly contributes to the variance in 
behaviour; however, it only adds 2% to the explained variance. Sheeran et a.l. (2003) 
argue that people are not accurate at judging the control they have over future behaviour; 
perceptions of control may be influenced by task familiarity; the implications of the task 
and, notably, mood. Loewenstein (2005) argues that we do not appreciate the extent to 
which our actual behaviour will be influenced or motivated by our emotional state, 
termed a 'cold-to-hot empathy gap'. At its extreme, Loewenstein (2005, p.S49) argues 
that "people often behave myopicaiJy under the influence of affect". In relation to the 
current study, the potential influence of emotion on people's behaviour is illustrated by 
theories of human decision-making, and the current understanding about how emotion 
can influence these processes. 
1.6.2. Decision-making theory 
Traditional models describing the process of decision-making, si milarl y to the Theory of 
Planned Behaviour, tend to assume that humans are rational actors. The Expected Utility 
Theory of decision-making, described by von Neumann and Morgensten (1947), 
proposed that a decision maker determines aU the possible outcomes of a decision, and 
then ascertains the probability of each outcome and its usefulness, in order to calculate 
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the expected utility of a decision. However. the fundamental assumption of Expected 
Utility Theory, that a decision maker acts rationally when considering any decisions and 
has infinite time and unbiased cognitive processe . is inherently flawed. 
Research has shown that people often display imperfections in their cogniti ve processes 
when making a decision; Simon ( 1957) described that people have a limited ability to 
consider differing options, termed 'bounded rati onality', and therefore, instead of an 
exhausti ve search, many people will make a decision when any satisfactory outcome is 
found, termed 'satisficing'. In cancer, key treatment decisions often invol ve highly 
complex information, which previous research has hown may be beyond many lay 
people's understanding (Chapman et al., 2003). A study by Sutherland ( 1990) ilJustrated 
the complexities of making a decision about cancer treatments and how individual 
differences in cognitive processes may influence the decision made. The researchers 
asked 50 lay people to make a hypothetical decision on whether to enter a clinical trial 
based on information provided. Three quarters of their sample did not indicate that 
considering both risks and benefits was pertinent to their decision. Similarly between 
26% and 54% of interpretations, by the participants, of statements about probability were 
incorrect. The decision-making process was neither robotic, nor exhaustive; rather it was 
based on another, unknown heuristic. 
Subsequent theories of decision-making recogni e that humans do not always act 
rationally when making decisions. In thei r Behavioural Decision-Making Theory, 
T versky and Kahneman ( 1981 ) argued that a per on's deci ion depends on the context in 
which the decision is made, and the differing values placed on the alternati ve outcomes. 
For example, Slevin et al. (1990) surveyed medical professionals, cancer patients and 
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healthy controls about whether they would accept a gruelling three month course of 
chemotherapy if it would extend their life expectancy. No Radiotherapists, 6% of 
Oncologists and I 0% of healthy controls stated they would accept this, compared to 42% 
of people with cancer. The context and personal value of opting for the chemotherapy 
was central to a person's decision whether to accept the treatment. 
Key decisions in cancer may arise on ly once and have a major impact for the patient; 
often there are high levels of distress at the time patients are asked to make serious 
decisions. Nearly 50% of doctors report patient anxiety as a barrier to involving them in 
treatment decision-making (Charles eta/., 2004). ln fact, orne researchers have argued 
that the lack of an absolute treatment and the increase in treatment choices can 
potentially exacerbate patients' distress (Kiesler & Auerbach, 2006). Decision-making 
theorist have speculated about severaJ mechanisms by which emotion may impact on a 
deci ion-making process. 
J .6.3. Emotion and decision-making 
Winkleman et a/. (2007) outline four main mechanisms by which emotion may have an 
effect on a person's decision-making. The first is by influencing cogniti ve processes 
such as recall; so, for example, a person who is anxious wi ll be more likely to interpret 
information as threatening. For example, Shapiro et a/. ( 1992) presented 40 women, at 
risk of brea t cancer, with a simulated video of an oncologi t pre enting results. The 
oncologist and results were identical; however, the oncologi t presented with either a 
worried or non worried affect. Women watching the ·worried' clinician remembered 
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significantly less information, viewed the situation as more severe, and experienced 
higher anxiety. 
The econd mechanism by which emotion may influence decision-making is by 
influencing a person's behaviour such as speeding up a search, or increasing avoidant 
behaviour, when exposed to negati ve information. The third is by being a direct 
component of a person 's decision, when a person bases a judgement on how they 'feel ' 
about the subject. The fourth mechanism is whereby people alter their behaviour or 
actions to regulate their emotional experience to either restore a previous emotional 
state; generate a preferred emotional state; or make their emotional state complicit with 
the demands of a situation. 
The fourth mechanism is central to the Decision Conflict Theory described by Janis and 
Mann ( 1977). Jani and Mann (1977) argued that the actual process of making a decision 
is inherently stressful , and propose that when a person is under stress they adopt adaptive 
decision-making styles. Pinquart et al. (2004) suggested that four of these styles are 
directly relevant to patients making treatment decisions about cancer: uncontlicted 
change, defensive avoidance, hypervigi lant, and vigi lant. Defensive avoidance and 
unconflicted change are indicative of a patient adopting a passive role in decision-
making and seeking others to either make the decision or recommend the correct choice. 
Hypervigilant decision-making is defined by the person attending to as much 
in formation as possible, but seizing upon a solution to allow relief from their emotion, 
potentiall y at the expense of choosing the correct option. Vigilant decision-making is 
akin to shared or acti ve decision-making, weighing up the benefits and disadvantages of 
a choice, and i seen as producing the highest quality decisions. The relationship of 
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patient di tress and participation in treatment decision-making is discussed further in 
section 1.8. 
1.6.4. Communication Model of Treatment Decision-making 
To date there is no unifying theory or model that has been extensively used to account 
for patient participation in treatment decision-making. The Shared Decision-making 
Model describes the ideal end state, but not the processes that would predict a patient' s 
participation. More general models predicting human behaviour, such as the Theory of 
Planned Behaviour, mostly focus on volitional behaviour and assume the person 
approaches their decisions rationally. More recent theories of decision-making, such as 
Decision Conflict T heory have recognised, however, that people do not act rationally 
when faced with decisions and that decision-making processes are affected by factors 
such as the context of the decision; personal values; and the person's emotional state. 
Siminoff and Stepp (2005) described a series of factors that may contribute to the level 
of a patient's partic ipation in treatment decision-making, in their Communication Model 
of Decision-making. There are three contributory elements in their model of the 
decision-making interaction: a) patient-physician antecedents; b) the communication 
c limate and c) the treatment decision (Figure 2). Patient and physician antecedents 
inc lude ocio-demographic characteristics. per onalities and competence in 
communication. The communication climate depends on the medical issue to be 
discussed, and is c reated by the participants. It can be dependent on the preference of the 
patient for participation, the emotional response of the patient as well as the physician's 
affecti ve demeanour. Finally, the model describes that the treatment decision is the 
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starting point for future interactions, underscoring that intervention at this point may be 
valuable in improving patient outcomes. The model has not been tested empirically, 
however, it provides an overarching framework to further consider what factors may 
influence patient participation in treatment decision-making. 
Patient-physician commwtication 
antecedents 
• Socio-demographic characteristics 
• Personality 
• Communication Competence 
The communication climate 
• Information and decision 
preferences 
• Disease severity 
• Emotional state 
. Role expectations 
The treatment 
decision 
Figure 2 Siminoff and Stepp (2005) The Communication Model of Decision-making 
1.6.5. Section summary 
In the context of medical treatment decision-making, it is fundamental to ensure the 
quality of a person's decision-making, as aJ I decisions require informed consent from the 
patient. The current dominant paradigm of health care delivery emphasises patient 
participation, with decisions about treatment being made collaboratively, between the 
health care provider and health care service user. However, in order to realise this ideal 
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premise of shared decision-making. it is vital to understand what may hinder or facilitate 
it. 
One of the most prominent theories of human behaviour in a health setting, the Theory 
of Planned Behaviour, has been criticised for being unable to explain the intention to 
action gap. In the context of treatment decision-making, many patients do not perceive 
that they participate, to the extent they indicate they wou ld prefer. Siminoff and Stepp's 
(2005) Communication Model of Decision-making provides an overarching view of the 
multitude of factors which may influence the treatment decision-making process, one of 
which is the patient's emotional state. Research into intrapersonal decision-making 
processes has shown that people do not always act rationally under stress, due to the 
influence emotion can have on cognition and behaviour. Many key decisions about 
cancer treatments occur in the early phase of adjustment. The current study sets out to 
understand further how patient distress at this time impacts on treatment decision-
making processes, especially as Siminoff and Stepp (2005) highlight that this is often the 
starting point for future interactions with the health care provider. 
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1.7. Factors influencing patient participation in treatment decision-making: A 
review of the literature 
Siminoff and Stepp (2005) have developed the Communication Model of Decision-
making to describe factors which may influence patient participation in decision-making. 
As the model has yet to be empirically tested, in order to summarise the existing 
literature on factors affecting participation in medical decision-making, a critical review 
of the literature was carried out. As the focus of the current study is the influence of 
patient distress on their participation in treatment decision-making, studies investigating 
this variable are central to the discussion. 
1. 7 .1. Literature review search strategy 
The literature review search strategy included all peer-reviewed journal articles 
published between 1988 and 2008 in the English language. All studies, regardless of 
methodology, were included; however, all were critically appraised to identify 
methodological limitations and potential biases. Previous research has found that 
patients express differing preferences for participating in treatment decisions, depending 
on the illness concerned (Arora & McHorney, 2000); therefore, the search was limited to 
studies with an adult cancer population measuring naturalistic decision-making. All 
studies investigating decision aids were excluded. 
Searches were carried out using Ovid databases: Medline, Psychinfo and The Cochrane 
Library and the EMBASE database: CINAHL. The search terms that were used are listed 
in Table 3; search terms were combined using Boolean operators. The Ovid database 
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search yielded 303 articles, and the EMBASE database search yielded 33 articles. The 
abstracts of these were then reviewed for relevance. In addition, cited and citing journal 
articles from key articles were followed up. Summary tables of the included articles are 
in Appendix 2. 
SEARCH TERMS USED 
Identification of 
Cancer; neoplasm; tumour; oncology 
Population 
Area of study Medical decision-making; treatment decisi.on-making 
Subject of study 
Patient participation; patient involvement; shared decision-making; 
joint decision-making 
Table 3: Search terms for rev•ew of lnerature 
1. 7 .2. Previous reviews of the literature 
Three previous reviews of the literature regarding influences on patient preference were 
found during the search (Benbasset et al., 2001, Hubbard et at., 2008; Say et al., 2006). 
The two later reviews (Say et al., 2006; Hubbard et al., 2008) do not acknowledge the 
previous reviews, which perhaps reflect the heterogeneous and sprawling nature of the 
evidence base, conducted in the fields of nursing, psychology and medicine. Benbasset 
et al. (1998) and Say et al. (2006) reviewed papers about preferences for participating in 
decision-making by patients with different conditions including cancer. Given this, they 
are not included in the current review. 
Hubbard et al. (2008) reviewed 31 quantitative papers published between 1994 and 2004 
about cancer patients' preferences for participation in treatment decision-making as well 
as what influenced this. This review reported that there is a trend toward younger, female 
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and better educated patients preferring more participation; however, demographic 
characteristics cannot fu lly account for the variance in patient preferences. The review 
also highlights that patient preferences are not being met and asks the reason some 
patients attain their preferred role and others do not. Unfortunately, its focus on papers 
investigating patient preference, does not allow this question to be addressed. The 
current review extends Hubbard et al. (2008) by reviewing papers that explored factors 
associated with patients' actual participation in decision-making, as well as factors 
associated with their preferences. Furthermore, the current review includes qualitative 
literature. 
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1.7.3. Patient preferences for participation 
Thirty relevant articles using quantitative methodology; eight articles using qualitative 
methodology; and one using mixed methodology (Hack et al., 1994) were found to have 
investigated variables influencing patient preference for participation in treatment 
decision-making (Appendix 2, Table 14 & Table 15). 
1. 7 .3.1. Socio-demographic variables 
Twelve studies found that there was a significant association between age and patient 
preferences for participation in decision-making (Appendix 2, Table 14): all the studies 
found that younger patients prefer a more active role. However, where possible to 
calcu late, the variance in preferred pruticipation explai ned by age is less than 3% 
(Beaver et al., 1996; Degner & Sloan, 1992). Equally, 12 studies found that there was no 
significant association between age and patient preferences. In general these were 
smaller studies, with 11 of the 12 having less than 150 participants. Therefore, it is 
possible that as age holds a weak association with patient preferences for participation, 
only larger studies have detected its effect. 
Six studies found that there was a significant association between education and patient 
preference for patticipation in decision-making (Appendix 2, Table 14): all these studies 
found that patients with more education prefer a more active role. Nine studies found no 
significant association between education and patient preference for participation in 
decision-making. 
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Many of the studies only include one gender due to the study population, such as breast 
or prostate cancer patients. Eight studies investigated whether gender was associated 
with preference for pa11icipation in decision-making: six studies found a significant 
association and two found no significant association. Agrun, all the studies reporting a 
significant association found that women preferred a greater level of participation than 
men. 
There is a general trend that women, people of a younger age and people who have 
received more education prefe r a more active role in decision-makjng. However, this 
trend is not always found to be significant, and a large study by Degner and Sloan 
( 1992), using multivadate analysis, found that socio-demographic variables only 
accounted for 15% of the variance in preferences for participation in decision-making, 
leaving 85% of the valiance unaccounted for. Therefore, it is not possible to define 
patients' preferences for participatjon based on static socio-demographic variables. 
1.7 .3.2. Emotional well-being 
Six quantitative studies have investigated whether a patient's emotional well-being or 
coping style affects their preference for participation in decision-making (Appendix 2; 
Table 15). Three studies found a significant association between emotional well-being 
or coping style and a patient preferring a more passive role in treatment decision-making 
(Hack & Degner. 1999; Ong et al. , 1999; Vogel eta/. , 2008). Three studies found no 
significant association (Janz eta!., 2004; Sainio & LaUJi, 2003; Wong et at., 2000). 
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Hack and Degner (1999) studied coping responses in 70 women diagnosed with breast 
cancer. They used cluster analysis to examine the women 's preference for participation 
in treatment decisions and psychological adjustment. Women whose coping response 
was classed as avoidant of their illness had significantly higher levels of anxiety, 
depression and confusion. Significantly more women who were moderately avoidant 
preferred a passive role, compared to women who were low avoiders, suggesting that 
patients who were not adjusting well to their diagnosis preferred less participation in 
treatment decisions. 
Similarly, in a study of 137 breast cancer patients, Vogel et al. (2008) found that patients 
who preferred a passive role in decision-making were significantly more depressed, and 
there was a trend that patients who prefened an active role in decision-making reported 
the lowest level of anxiety. However, the majority of patients were below the clinical 
cut-off for depression and anxiety on the Hospital Anxiety and Depression Scale. In 
addition. the difference in the average depression scores for women prefening different 
roles was less than three points on the scale. Therefore, while this trend is statistically 
significant, it is unclear if it is clinically relevant. 
Nevertheless, findings from six qualitative studies support the hypothesis that emotional 
well-being can affect a patient's preference for participation in decision-maki ng (Charles 
et at. , 1998; Cohen & Britten, 2003; Elit et al. , 2003; Hack et a/., 1994; Sainio et al., 
2001 ; Sanders & Skevington, 2004). Cohen and Britten (2003) interviewed 19 male 
prostate cancer patients, who had been given their diagnosis in the same consultation as 
being asked to make a treatment decision. The participants had difficulty concentrating 
on the decision-making process, and described welcoming a directive approach. 
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Similarl y, Elit et a/. (2003) interviewed 21 female gynaecological cancer patients; the 
participants did not receive their diagnosis and make a treatment decision in the same 
consultation; nevertheless, they described feeling overwhelmed during the period in 
which their treatment decisions were made. 
The other three quantitative studies failed to find a significant association between 
patients' mood and their preferences for participation in decision-rnaldng (Janz et al., 
2004; Sainio & Lauli, 2003; Wong et al., 2000). Sainio and Lauri (2003) did not find a 
signi ficant association between the importance patients place on participation in 
decision-making and their score on a ten point depression scale, in a group of 273 
patients, diagnosed with various types of cancer, who were up to 15 years post-
diagno is. This retrospective method is flawed in two ways. Firstly, mood is not stable, 
and therefore investigating the association of current mood and preference for 
participation in decision-making may not be a valid measure of the patient mood at the 
time of the actual treatment decision-making consultation. Secondly, mood has been 
shown to bias recall; therefore, people may not have an accurate recall of their 
preference for patticipation. As well as the di fficulties associated with a retrospecti ve 
design, the use of an idiosyncratic measure of mood and lack of consideration of 
extraneous variables, result in the fmdings of this study lacking conviction. 
Ln contrast to the methodology used by Sainio and Lauli (2003). Janz et a/. (2004) 
surveyed I 0 I breast cancer patients prior to their treatment decision-making meeting to 
establish their preferences for participation in deci ion-making. This prospective 
methodology allows a more valid investigation of the relation hip between mood and 
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patients' preference for participation; nevertheless, no significant association with the 
patients' level of anxiety or depression was found. 
Therefore, there i mixed evidence about whether a patient's emotional well-being 
affects their preferences for participation in decision-making. Evidence from several 
qualitative studies has shown that patients identify that thei r emotional well-being at the 
time of the decision partly dictates the role they wou ld prefer to take; however, this is 
not always borne out in the quantitative literature. The quantitative literature completed 
so far is mini mal and has some methodological flaws. Therefore, further research is 
required to examine whether patients' emotional well-being influences their preferences 
for participation in decision-making. 
1. 7 .3.3. Other variables 
Other studies have investigated various contextual variab les associated with patient 
preferences for participation in decision-making, including physical well-being or 
disease progression (Sainio & Lauri , 2003; Blanchard er a/., 1998; Stewart er al., 2000; 
Barry & Henderson. 1996); perception of choice (Jansen er al .. 2004; Vogel et al., 
2008); perception of responsibility for treatment choice (Charles er a/., 1998; Cohen & 
Britten 2003; Kenney eta/. , 1999); knowledge of treatments (Kraetschmar er al., 2004; 
Charles eta/ .. 1998; Elit era/., 2003; Henman eta/., 2002; Husain eta/., 2008; Kenney 
eta/., 1999; Sainio et al., 2001); and trust in the doctor (Kraetschmar eta/.; 2004; Kenny 
er a/., 1999; Henman et a/ .. 2002; Husain et at., 2008; Hack er a/., 2004). 
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1.7.4. Patients' actual participation 
Ten quantitative, and one qualitative, studies were found to have investigated patients' 
actual participation in treatment decision-making (Appendix 2; Table 16 & Table 1 7). 
One of these studies (Sainio & Lauri, 2003) was also included in the review looking at 
factors influencing patient preferences. Only one study has investi gated factors which 
explain the level of concordance between patients' preferred and actual participation in 
decision-making (Hawley et at., 2007). The published studies do not have the same 
uniformity of methodology apparent in those examining patient preferences, for example 
the studies use a range of measures. which makes drawing general conclusions more 
difficult. 
1.7.4.1.Socio-demographic variables 
Six quantitati ve studies investigated whether age is associated with a patient's actual 
level of participation in decision-making (Appendix 2; Table 16). Only two studies 
concluded that age significantly affected a person's actual participation in medical 
decision-making (Fischer et at. 2006; Pinquhart et al., 2004). The other four studies 
found no significant association between age and participation in medical decision-
making (Hawley et a/., 2007; Liang et at., 2002; Maly et a! .. 2004; Sainio & Lauri , 
2003). 
In their study of 126 prostate cancer patients, Fischer et al. (2006) found that younger 
men were significantly more likely to report more active participation in their medical 
decision-making. This seems to mirror the trend identified that younger patients prefer 
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more active participation. Pinquart et al. (2004) found the same trend in their study 
which used a questionnaire based on the decision-making styles de cribed by Janis and 
M ann ( 1977). The study of 140 patients, with di fferent cancer types, found that age was 
positively a sociated with unconflicted change, that is adopting a passive role in 
decision-making, and negati vel y associated with vigilant decision-making, that is 
adopting a rational shared or active role. Both studies rel ied on univariate analysis of the 
data however, which may not have accounted for compounding effects of other 
variables, such as severity of disease. 
In a larger study of 1038 female breast cancer patients, Hawley e1 at. (2007) concluded 
that age was not significantly associated with a patient's actual participation in decision-
making. By dividing their sample into three age bands. Hawley et at. (2007) investigated 
the odds of each age band experiencing different levels of participation, controlling for 
other socio-demographic and illness variables. Their only significant fi nding was that the 
middle age group, aged 45 to 64 years, was nearl y two times more likely than the older 
age group to report that the surgeon made the decision, as opposed to a shared decision-
making process. This would indicate that younger women had less participation in the 
decision-making process, than the older age group, which counters Fischer et al. 's 
(2006) finding. 
Overall, 66% of Hawley et al. 's (2007) sample reported the ri ght amount of participation 
in the decision-making process. Of note, however, the two younger age groups were 
significantly more likely to report too li ttle participation compared to the oldest age 
group. This finding shows that younger women were less involved than they had wanted 
to be. As such, age is the only factor that has been found to be ignificantly associated 
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with whether patients attain their preferred role in treatment decision-making and raises 
the question as to what variables impacted on thee participants· ability to attain their 
preferred level of participation. 
Three studies investigated whether education or cogniti ve ability were associated with a 
person 's actual level of participation in treatment decision-making. Siminoff and Fetting 
( 1991) carried out a behavioural analysis of 100 consultations with female breast cancer 
patients, to investigate factors affecting a patient's acceptance or rejection of their 
doctor's treatment recommendation. Patients with less formal education were 
significantly more likely to accept their doctor's recommendation for treatment. 
Similarly, Pinquart et al. (2004) found higher cogniti ve abilities were associated with 
vigilant, or rationaL decision-making, and lower cogniti ve abilities were associated with 
hypervigilant, or panicked, decision-making. In contrast, Sainio and Lauri (2003) fou11d 
no significam association between the level of formal education and participation in 
medica l decision-making. although again it is important to note the l imitations of this 
study that have been previously discussed. This study also found no significant 
association between patients' level of participation in medical decision-making and their 
gender. Neither did Pinquart et a/. (2004), the only other study to investigate this. In 
summary, there is some evidence that higher levels of education, but not gender, may be 
associated with greater participation in treatment decision-making. however, the paucity 
of tudie investigating these variables does not allow firm conclusions to be drawn. 
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1.7.4.2. Emotional well-being 
Four quantitative studies and one qualitative study investigated the impact of a patient's 
emotional well-being or coping style on their actual patticipation in medical decision-
making (Appendix 2; Table 16 & Table 17). Me Yea et al. (200 I ) interviewed 25 low 
income women with breast cancer and conducted thematic analysis of the transcripts. 
The authors assumed that women wou ld engage in rational style of decision-making, 
actively gatheri ng information about treatment options and considering the advantages of 
each alternative. However, thematic analysis of their data revealed that women reported 
that this did not happen due to the stressful nature of the situation. The authors identified 
four patterns in the women's treatment decision-making styles, which depended on how 
they were affected by emotion: panicked, avoidant, passive and rational. The largest 
group of participants were rational, describing the ability to regulate their fear and 
engage fully in decision-making. The idea that patients employ decision-making styles to 
regulate their emotions during decision-making is in line with decision-making theory 
(e.g. Janis & Mann, 1977). Given the inductive methodology, conclusions cannot be 
drawn around the validity of the four identified patterns; nevertheless, McVea et al. 's 
(200 I ) study suggests that patients who are suffering greater distress have difficulties 
participating in decision-making. 
In their study, Sainio and Lauri (2003) measured their participants' mood using a ten-
item screening tool for depression. Using this tool, one third of their sample was classed 
as depressed. The study found no significant association between whether a person was 
depressed and whether they had participated in decision-making. The previous 
methodological concems about this study, in particular, the method of comparing a 
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patient's present mood to retrospectively reported participation in treatment decisions 
when some participants were significantly past the initial diagnosis, mean that this 
finding is unconvincing. 
Fischer et al. (2006) investigated whether patients' level of participation in treatment 
decision-making was associated with their coping style. It was hypothesised that patients 
classed as using an active coping style would be significantly more active in decision-
making; however, univariate analysis again did not indicate any significant association. 
In addition, similarly to Sainio and Lauri (2003), Fischer et al. (2006) employed a 
retrospective methodology with pruticipants ranging from zero to three years post 
diagnosis, again weakening the validity of the study's findings. 
In a study of 79 patients diagnosed with various cancer types, Peterson et al. (2003) 
measured the relationship between anxiety and depression and a patient's reported 
decision-making style. Decision-making style was measured using a new tool, developed 
by the authors. Participants had recently had a treatment consultation with a doctor and 
were awaiting the start of their treatment. Previous research has shown that patients' 
anxiety decreases immediately following treatment decision-making (Morris & Royle, 
1988); however, compru·ed to the retrospective methodology employed by Fischer et al. 
(2006) and Sainio and Lauri (2003), Peterson et al. 's (2003) time frame of study 
provided a more val id measure of the association between patient's emotional well-being 
and their participation in treatment decision-making. However, despite this, no 
significant associations were found between the style of a person's decision-making and 
their current mood. Pinquart et al. (2004) also failed to find a significant association 
usi ng a similar methodology. 
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The four quantitative studies which have investigated whether a patient's emotional 
wellbeing is associated with their acmal level of pru1icipation in decision-making, have 
found no significant relationship. This is at odds with qualitative research (McVea et al., 
2001) as well as researchers' hypotheses (e.g. Fischer et al. , 2006). The studies have 
differing methodologies and have used dissimilar measures, which make drawing 
comparisons and conclusions difficult. In addition, similarly to research investigating 
whether emotional well-being affects patient preferences for participation, some of the 
existing studies have lacked temporal validity in their methodologies, intervie wing 
patients years past their diagnosis. Therefore, there is a need to fut1her investigate the 
impact of patient's emotional well-being on their actual participation in medical 
deci sion-making. 
1. 7 .4.3. Other variables 
Other variables have also been found to account for variance in patient' s actual 
pat1icipation in medical decision-making including the stage of thei r disease (Fischer et 
al. , 2006), the availability of treatment options (Hawley et al. , 2007; Liang et al., 2002), 
their level of social support (Maly et al. , 2004; Liang et al. , 2002; Sainio & Lauri , 2003), 
the level of patient knowledge (Siminoff & Fetting, 1991) and whether there was a direct 
invitation to participate (Street et al. , 1995; Maly et at. 2004; Liang et al. 2002). 
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1.7.5. Section summary: Conclusion of literature review 
The majority of the research investigating variables as ociated with patient participation 
in decision-making has focussed on understanding patient preferences. However, despite 
continued research over two decades, discrete variables which consistently impact upon 
the role a patient wishes to take in decisions about their treatment for cancer have not 
been establi shed. Further, the proportion of patients achieving their preferred role varies 
widely. Given this, and that it is a patient's actual partic ipation in decision-making, or 
achieving their preferred role, which is associated with improved psycho-social 
outcomes, it seems that continuing to focus on patient preferences, and static 
determinants of these, may limit the relevance of this body of research to clinical work. 
Less research has looked at factors influencing a patients' actual participation in 
treatment decision-making. The clinical uti lity of the research could be increased by 
examining contextual factors, which may influence a patient's actual role in treatment 
decision-making and their ability to attain the role that they prefer. Identifying these 
contextual factors may highlight areas of possible intervention. One of the most evident 
challenges is that treatment decisions for cancer often occur in the early stage of 
adjustment, when patients are distressed. The impact of patient distress on their 
participation in treatment decision-making is the focus of the current study and is further 
di cussed in the next section 1.8 
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1.8. Patient distress and decision-making 
Theoretical models speculate that emotion influences a person 's decision-making 
process, either by affecting the cognitive processes used when making a decision, or by 
altering a person 's behaviour to help regulate the stress caused by the situation. When 
treatment decisions for cancer are required, patients are often in the early stages of 
adjustment and experiencing hi gh levels of distress. Thi s section draws together some of 
the previously discussed research to understand how distress may affect patient 
participation in treatment decision-making, and to introduce the concept of emotion 
regulation. 
1.8.1. The impact of distress on the treatment decision-making process 
Qualitative accounts by patients with cancer describe how distress impacts on their 
desire to be involved in the decision-making process and on their ability to actually be 
involved, for example by affecting their concentration (McVea et al. , 2001) or by 
creating a feeling of pressure to be involved (Hack et al., 1994). However, to date, 
preliminary quantitative research with cancer patients investigating the impact of distress 
on their decision-making process has not provided conclusive findings to support the 
theoretical models or qualitative findings. A patient's emotional well-being has not been 
found consistently to be associated with, or to predict, their preferred decision style or 
their actual level of participation with treatment decision-making. At present, the 
research remains limited and beset by methodological inconsistencies, such as 
retrospective data collection, diverse procedures and measures, and univariate analysis. 
Therefore, there is a need to re-assess whether distress does impact on patient 
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preferences and participation in treatment decision-making using common measures, and 
a prospective methodology. 
Furthermore, however, the research into patient participation in treatment decision-
mak ing has left another fundamental question unanswered. Research has shown that for 
a significant proportion of people in treatment decision-making their role in the process 
is not what they had initially wished for (Gatellari et al., 200 I ). Current policy explicitly 
states that patients should be allowed to be involved in decision-making if they so wish 
(NICE, 2002). and the importance of this is highlighted by research showing the benefit 
that it can have for patients' psychosocial outcomes (Gatellari et at., 200 1; Keating et at., 
2002). Yet little or no research has explored what factors account for patients achieving 
the level of participation that they would prefer. Hawley et a/. (2007) provides the 
exception. establishing that younger women amongst her patticipants were less likely to 
take their preferred role in decision-making. This leads to the question of what it was 
about these participants, or their consultations, that led to the mismatch between their 
preferred and actual roles in decision-makjng. 
Criticism of the Theory of Planned Behaviour has highlighted that there is often a gap 
between a person's expressed intention and ultimate action. The evidence from decision 
theory shows that high emotion can impact negatively on people's planned behaviour. It 
is po sible therefore that distress influences whether a patient takes their preferred level 
of participation. 
62 
1.8.2. Emotion regulation 
Responding optimally and adaptively to the demands of different situations requires a 
person to regulate their emotions: inc reasing emotional responses which promote useful 
behaviour and decreasing emotional responses which promote ineffectual behaviour. 
"Emotion regulation refers to the processes by which individuals influence which 
emotions they have, when they have the m, and how they experience and express these 
emotions" (Gross, 1998, p. 275). Given the impact that emotion can have on processes 
during decision-making, a person's ability to regulate their emotions at this time may be 
key to their participation in decision-making for two possible reasons. 
Firstly, emotion regulation may moderate the relationship between distress and 
pruticipation in treatment decision making. Greater difficulties with emotion regulation 
may result in a person e xperiencing higher levels of distress when attempting to respond 
to the demands of the situation; the higher distress could then affect decision making in a 
number of ways (Winkleman et al., 2007). Alternatively, it has already been theorised 
that emotion regulatio11 may mediate the re lationship between distress and participation 
in treatment decision making (Janis & Mann, 1977; Luce, 2005). A mediator variable 
can be understood as explaining the relationship between two other variables (Baron & 
Kenny, 1986). In Decision Conflict Theory, for instance, Janis and Mann (1977) suggest 
that a person uses their decision making style to regulate their e motion; the decision 
making style mediates the way a person's distress influences their levels of participation. 
In fact, emotion regulation strategies may both moderate and mediate distress in relation 
to treatment decision-maki ng; however, the present study will focus on examining 
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whether emotion regulation moderates the impact of distress on treatment decision-
maki ng. 
The concept of emotion regulation has developed from research into the human 
behaviour when under stress. Folkman and Lazarus ( 1985, p.152) describe stress as "a 
re lationship between the person and the envi ronment, that is appraised by the person as 
relevant to his or her well-being, and in which the person's resources are taxed and 
exceeded" . They further described a person's cognitive and behavioural eff01t s to 
manage the stress as coping responses. Coping responses can be either problem-
focussed, with the goal of fixjng the stressor, or emotion-focussed, with the goal of 
ameliorating negati ve emotional experience. Emotion-focussed coping strategies are at 
the foundation of the concept of emotion regulation. 
Gross (1999) makes a strong di stinction between coping and emotion regulation. He 
argues that coping encompasses a broad range of responses to a cha llenging situation 
including practical, non-emoti onal strategies, and often occurs over an extended period 
of tjme, such as the first year after being diagnosed with cancer. Emotion regulation 
focuses on the active co-ordination of a person's positi ve and negative emotional 
response at a specific time point. For example, Oatley and Johnson-La ird (1987) 
described that all our experiences are appraised in terms of our goals and plans. Specific 
basic emotions: happiness, sadness, anger, fear or disgust, are e licited at certain key 
junctures toward our trying to achieve those goals or plans and consequently guide our 
reacti ons. 
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Fundamentally, emotion regulation strategies can be conscious or unconscious and 
modulate rather than eliminate both negati ve and positi ve emotional responses. There are 
potentially limitless numbers of emotion regulation strategie . One conceptualisation is 
that the generation of emotions unfolds along a timeline, beginning with the evaluation 
of a cue. This 'emotion-generati ve process' is multifaceted and involves our cognitive, 
behavioural and physiological systems. Different emotion regulation strategies may be 
more effective at regulating different systems at different stages of the process (Gross, 
2002). Gross ( 1998) developed a model to differentiate which speci fie emotion 
regulati on strategies may be more relevant at different stages of the emotional response 
(Figure 3). Responses may be categorised as antecedent-focused strategies. which are 
utili ed before our full emotional response is acti vated, and response-focused strategies, 
which are utili ed after an emotion has been generated. Antecedent-focused strategies 
include selecting or modi fying situations to regulate emotions, concentrating on specific 
aspect. of a situation or assigning meanings to a situation. Response-focused strategies 
focus on attempts to influence the experience or expression of an emotional response. 
As an illustrative example, a cancer patient attending a medica l consultation may not be 
able to utili se emotion regulation strategies classified as situation selection or 
modificati on, as the simation may be unavoidable, in order to obtain treatment. 
Employing attentional deployment strategies may be detrimental to the person's ability 
to consent to treatment, if they were to focus attention away from threatening, yet 
important, information. Some cogniti ve change or reapprai ·al trategies may contribute 
directly to their emotional well-being. However. the objecti ve fact of facing a life-
threatening illness may not be easil y re-appraised, hypotheticall y leaving the person 's 
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re ponse modulati on strategies as key m regulating their emotion during a medical 
consultation. 
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Figure 3: A process model of emotion regulation, adapted from Gross (2002) 
The focus of James Gross' extensive work has been on two potential emotion regulation 
strategies: cogniti ve reappraisal, an antecedent-focussed strategy, and emotion 
suppression, a response-focussed strategy. In a study investigating the cognitive 
consequences of uti lising each strategy, Richards and Gross (2000) found that 
experimenta l research participants asked to employ emotional suppression strategy when 
di cussing distressing slides, had significantly poore r verbal recall than participants 
asked to employ cogniti ve reappraisal strategies or a signed to a control group. Much of 
Gross' research has focussed on experimental manipulation of participants' conscious 
emotion regulation style rather than naturalistic observation. It is possible that the act of 
asking participants to employ an unfamiliar emotion regulation strategy, artificially, may 
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impact on their cognitive functioning, as opposed to the strategy itself. However, a 
further individual differences study found participants who habitually used suppression, 
as opposed to cogniti ve reappraisal, had significantly poorer memory (Richards & Gross, 
2000). Richards and Gross (2000) work shows the u e of adaptive regulatory strategies 
may moderate a person's negati ve emotional experience and, thereby, the impact on 
cognitive processes and achievement of their goal. Therefore, it is also speculated, the 
impact of a person's distress on the treatment decision-making process will be 
moderated by their ability to regulate their emotions successfu lly. 
Support for this speculation is found in a study by Collie et at. (2005). This study 
explored the relationship between self-efficacy, coping styles and difficulties interacting 
with health care professionals, in 89 women diagno ed with breast cancer. The study 
found that higher self-efficacy for emotion regulation was significantly associated with 
less problematic interactions with the health care team. This study not only suggests that 
a person's emotion regulation may influence their ability to achieve health care goal s, 
but also highlights the interplay between patients' emotional well-being and their 
engagement with health care services. 
Furthermore, Petersen et at. (2003) failed to find a signi ficant association between a 
patient 's decision-making style and their emotional well-being, discussed earlier in 
section 1.7.4. However, the study did show that the participants reported decision-
making style was associated with coping strategies. In particular, participants describing 
themselves as more active in the decision-making process scored signi ficantly higher on 
a 'focus on the positive· scale. whereas those describing themselves as passive in the 
decision-making process scored significantly higher on an 'avoidance' scale. These 
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studies provide rudimentary support that a persons' regulatory strategies may influence 
thei r level of participation in medical consultations. 
1.8.3. Section summary 
Research from the human decision-making tradition has found that stress can impact on 
the decision-making process. In the current climate, there is an increasing emphasis on 
the importance of offering patients the opportunity to participate in health care treatment 
decision-making. Often key decisions about cancer treatments occur early in a person 's 
emotional adjustment to their i llness; therefore it is reasonable to assume that the level of 
distress may impact on their ability to be involved in the decision-making process. 
However, research so far has not conclusi vely establi shed whether, or how, a patient's 
emotional well -being impacts on their participation in treatment decision-making. 
Theories of emotion regulation describe how people have differing abilities to moderate 
their emotions to allow them to achieve their desired goals. As such, it is possible that 
the impact of a person 's emotional well-being on their participation in treatment 
decision-making is moderated by several factors, including their own and their doctor's 
ability to regulate their distress. 
68 
1.9. Current study 
The current research is an exploratory study looking at the relationship between distress, 
emotion regulation and patient pa1ticipation in treatment decision-making. It also aims to 
contribute to the body of research exploring whether achieving a preferred role in 
treatment decision-making affects longer-term psychological adjustment to illness and 
satisfaction with the decision made. This study sets out to expand on previous research in 
the area in two speci fic ways. Firstly, it will use a prospective methodology, approaching 
patients at the time of decision-making, to ensure the timely and judicious measurement 
of the variables. Secondly, although the study will explore the association of distress 
with patient preferences for and experiences of treatment decision-making, the main 
focus of study is on whether distress affects patients attainment of their preferred role. 
Understanding the association between a patient's distress and their participation in 
decision-making is important. Resolving this interplay wi ll help identify factors that may 
hinder a patient achieving the ir preferred role, and thereby ascertain opportunities for 
inte rvention which may produce benefits in their psychosocial outcomes. In this section, 
the reviewed literature is briefly summarised to explain each of the study hypotheses. A 
summary of the research questions and hypotheses is in Figure 4. 
1.9.1. Study aims, research questions and hypotheses 
The primary aim of the current study is to explore the impact of patient distress on 
participation in treatment decision-making. Specifically, it asks whether a patient's 
di stress is associated with their preferred level of participation in treatment decision-
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making, and their ability to attain this level of participation. It also asks whether a 
patient' ability to regulate their distress will moderate the relation hip between patient 
distre s and their attainment of their preferred role in treatment decision-making. Finally, 
it explores whether patient participation in treatment decision affects psychological 
adjustment to their illness and satisfaction with the decision made. 
The first hypothesis is that patients preferring a passive role in decision-making will 
have a higher level of distress. Although there is mi xed evidence about the association of 
mood with preferences for participation in decision-making, studies which have found a 
significant association report that depression and anxiety is associated with a passive or 
avoidant approach to treatment decision-making (Hack eta/., 1994; Vogel et at., 2008). 
Similarl y, the econd hypothesis is that patients taking a pa sive role in decision-making 
wi ll have a higher level of distress. Although previous quantitative tudies have failed to 
find a significant association (Peterson et al., 2003; Sainio & Lauri, 2003), qualitative 
accounts suggest distress can interfere with patient participation (McVea et al., 2001 ). 
The third, and main, hypothesis is that patients who do not attain their pre ferred level of 
participation in treatment decision-making will have higher levels of di stress. Although 
no previous studies have examined this, it is well established that the concordance 
between patients' preferred and actual roles in decision-making is variable (Gatellari et 
a/., 200 I ). Furthermore, according to decision-making theory, distres interferes with 
decision-making processes, and it would therefore seem reasonable to hypothesise that 
higher distress will be associated with patients not achieving their preferred role. 
Following on from this the fourth hypothesis is that patients who do not attai n their 
preferred level of participation in treatment decision-making have greate r difficulty with 
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emotion regulation. In order to fulfill an intended behaviour, people must regulate their 
emotions to suit the demands of the situation. It is also therefore hypothesised, that a 
per on's ability to regulate their emotions will moderate the association between their 
distress and their attainment of their preferred role in the treatment decision-making 
consultation. If there is a sufficient sample, the relationship between distress, emotion 
regulation and participation in treatment decision-making will be considered using 
multi variate stati stics, also accounting for the socio-demographic variables, age and 
gender. 
The final two hypotheses are that patients achieving their preferred role in treatment 
decision-making will have better psychological adjustment and higher satisfaction with 
the decision made. The trend towards encouraging participation in treatment decision-
making is supported by evidence that participation leads to improved psychosocial 
outcomes; however, there is also some evidence that achieving a preferred role is key to 
improved psychological adjustment (Gatellari et a/., 200 I ) and sati sfaction with the 
decision made (Keating et al. , 2002). 
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Research Questions: 
• What is the relationship between distress and patient participation in treatment 
decision-making? 
• Does a patient's ability to regulate their emotion affect the relationship between 
distress and participation in treatment decision-making? 
• How does patient pa1ticipation in treatment decision-making affect psychological 
adjustment to illness and satisfaction with treatment decision? 
Hypotheses: 
H 1: Patients who prefer passive roles in decision-making will have higher distress 
compared to those who prefer shared or active roles. 
H0: There will be no difference in the distress of patients preferring different roles. 
H2 : Patients who are passive in decision-making will have higher distress compared to 
those who take a shared or active role. 
Ho: There will be no difference in the distress of patients taking different roles. 
H3: Lower distress will be associated with patients attaining their preferred role in 
decisi.oo-making 
Ho: There will be no association between distress and a patient attaining their preferred 
role in decision-making 
H.4: Better emotion regulation will be associated with patients attaining their desired role 
in decision-making 
H0: There will be no association between emotion regulation and a patient attaining their 
preferred role in decision-making 
H5: Emotion regulation will moderate the relationship between distress and patients 
attaining their preferred role in decision-making 
Ho: Emotion regulation will not moderate the relationship between distress and patients 
attaining their preferred role in decision-making 
H6: Patients attaining their preferred role in treatment decision-making will have better 
psychological adjustment to the diagnosis of cancer 
Ho: There will be no difference in psychological adjustment between pat.ients attaining, 
or not allaining their preferred role. 
H1: Patients attaining their preferred role in treatment decision-making will have higher 
levels of satisfaction with the decision made. 
Ho: There will be no difference in satisfaction with the decision made between patients 
attaining, or not attaining their preferred role. 
Figure 4: Summary of Research Questions and Hypotheses 
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2. CHAPTER TWO: METHODOLOGY 
2.1. Study design 
The study is a longitudinal observational design. Cross-secti onal surveys were used at 
three points in a patient's care pathway to explore the re lationships between distress, 
emotion regulation, participation in treatment decision-making, and psychosocial 
outcomes. Distress and preference for participation was measured before the patient's 
treatment decision-making consultation; emotion regulation, actual participation and 
psychosocial outcomes were measured after the treatment decision-making consultation; 
and psychosocia l outcomes were measured again at three months follow up. 
2.1.1. Setting 
The study was caiTied out in a district general hospital's cancer out-patient department. 
The hospital serves a regional population of approximate ly 150 000 people. 
2.2. Description of measures 
The instruments selected to measure each of the study variables and reasons for selection 
are discussed be low. Table 5 summarises the measures used in the study. 
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2.2.1. General Health Questionnaire 12 (Goldberg & Williams, 1989) 
Patient distress was measured using the General Health Questionnaire 12 (GHQ-12). The 
GHQ- 12 is a 12-item instrument used to screen for psychological distress, by asking 
respondents to rate, on a four-point scale, how frequentl y different problems have 
bothered them in the last week. Example items inc lude: ' fe lt capable of making decisions 
about things'; 'been feeling unhappy and depressed' or 'been feeling reasonably happy, 
all things considered'. 
The scale has good internal consistency (Cronbach's a = 0.87) and was originaUy 
validated against clinician interview (r = 0.80) (Goldberg & Williams, 1989). There are 
severa l diffe rent scoring methods; for the current study, a Likert scoring scale was used, 
giving a core for each item between zero and three. The potential range of scores is 
from zero to 36. For this scoring method, a cut-off between I I and 12 points is used to 
measure caseness (Goldberg eta/., 1997). 
The GHQ- 12 does not include somatic items, which can be confounded by poor physical 
health. The measure was chosen for the current study, therefore, due to its applicability 
in a physical health setting and its concision, as participants were asked to complete it at 
the time of their appointment with the Oncologist. 
2.2.2. Difficulties in Emotion Regulation Scale (Gratz & Roemer, 2004) 
The Difficulties in Emotion Regulation Scale (DERS) was used to measure participants' 
ability to regulate their emotions. The 36-item questionnaire provides an overall measure 
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of emotion regulation and has six subscales: 'non-acceptance of emotional responses'; 
'difficulties in engaging in goal-directed behaviour'; 'impul e control'; 'awareness of 
emotions'; 'access to emotion regulation strategies' and 'emotional clarity'. ·Non 
acceptance of emotional responses' measures a person's secondary emotional response 
to their negati ve emotions. 'Difficulties in engaging in goal-directed behaviour' 
measures difficulties in accomplishing tasks when experiencing negati ve emotions. 
' Impulse control' measures the abi lity to control behaviour when upset. 'Awareness' 
measures attenti veness to emotions. 'Strategies' measures self effi cacy in regulating 
emotions, and 'clarity' measures the extent to which a person knows what they are 
feeling. 
Respondents are asked to indicate how often each of the items appl ies to them on a five-
point scale: almost never; sometimes; about half the time; most of the time, or almost 
always. Example items include: 'I experience my emotions as overwhelming or out of 
control'; 'when I am upset, I can still get things done'; and 'when I am upset, I have 
difficulty focussing on other things' . The potential range of scores is 36 to 180: a higher 
score on this scale means greater difficulty with emotion regulation. 
The scale is relati vely new; however, preliminary psychometric studies show that it has 
good construct validity with significant associati ons with the Generalized Expectancy for 
Negative M ood Regulation Scale (NMR) (Catanzaro & Mearns, 1990) (r=0.69, p<O.Ol ), 
an established measure of emotion regulation, good internal con istency (Cronbach's a= 
0.93; >0.80 for each subscale) and good test-retest reliabi l ity over eight weeks (r=0.88, 
p<O.OI ). The population mean score is reported as 79.33 (s.d. 19.76) (Gratz & Roemer, 
2004). The DERS was chosen for the current study as it provides a comprehensi ve 
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measure of emotion regulation, and includes items assessing access to emotion 
regulation trategies perceived as effective, which are not inc luded in the NMR. 
2.2.3. Decision-making preference statements (Sutherland et al., 1989) 
Patient preferences for participation in the decision-making consultation, and their 
perception of their actual participation, were measured by asking pruticipants to choose 
which of fi ve statements best described their opinion. The statements were then 
classified as representing active, shared or passive decision-making (Figure 5). 
The doctor should make the dec isions using a ll 
that's known about the treatments. 
The doctor should make the dec isions but 
seri ously consider my opinion. 
The doctor and I should make the decisions 
together on an equal bas is 
I should make the dec isions, but strongly consider 
the doctor's opinion. 
I should make the decisions using all I know or 
learn about the treatments. 
} 
Figure 5: Decision-making preference statements (Sutherland et al., 1989) 
This technique was first described by Strull et a/. ( 1984) and subsequently used by 
Sutherland et at. ( 1989). Since development, this tool has been used in fu rther research 
into patient preferences in decision-making in cancer (Butow eta!., 1997; Jansen et al., 
2006; Ong et at. , 1999; Stiggelbout & Kiebert, 1997). It was also used in developing and 
validating the Autonomy Prefe rence Index (API) (Ende et al., 1989), a widely used 
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instrument. with good test-retest reliabi lity (decision-making prefe rence: r=0.84) and 
good internal consistency (Cronbach's a = 0.82), for measuring patients' preference for 
autonomy in medical situations. Patient's responses corre lated highJy significantly with 
their score on the API (r=0.54, p<O.O I). The tenses of the tatements were modified and 
used to assess participants' perception of their actual role in treatment decision-making. 
This methodology has been used previously by Janz et al. (2004). 
This method of measuring patients' preferences for participation, and their perception of 
their participation, was chosen for three reasons. Firstly, it is an established tool withjn 
re levant re earch about patient preferences, allowing the current study to be compared to 
previous fi ndings. Secondly, the statements allow participants to be categorised into 
active, passive and shared roles, which is comparable to other wide ly used tools such as 
the Control Preferences Card-Sort (Degner eta/., 1997). Thirdly and fi nally, the tool was 
chosen for its brevity compared to other self-report tools, used to categorise preferences 
and perceptions of participation. 
2.2.4. Mental Adjustment to Cancer Scale: Fighting spirit/ Helpless-
hopeless subscales (Watson et al., 1989) 
Psychologica l adjustment was measured using two sub-scales from the Mental 
Adjustment to Cancer Scale, a well -established instrument designed to measure 
adjustment responses to a diagnosis of cancer. The original scale has 40 items, 
comprising fi ve discrete sub-scales measuring different adj u tment styles: fighting spirit, 
helples !hopeless, anxious pre-occupation, fatalistic, avoidance. The scale has been 
fo und to have a satisfactory concordance with the independent ratings of a psychiatrist 
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(agreement obtained in 79% of cases, kappa=0.72). The different subscales have been 
shown to have varying internal consistency (see Table 4). 
Respondents are asked to indicate how much each item on the scale applies to them on a 
four point scale: Defi ni tely does not apply to me; does not apply to me; applies to me; 
definitely applies to me. 
Watson et al. Schwartz et al. Osborne et al. 
(1988) (1992) (1999) 
Fighting Spirit 0.84 0.78 0.85 
Anxious Preoccupation 0.65 0.43 0.65 
Fatalism 0.65 0.67 0.64 
Helpless-Hopeless 0.79 0.83 0.81 
Avoidance One item only One item only One item only 
Table 4: Cronbacb's alpha for Mental Adjustment to Cancer sub-scales 
High levels of fighting spirit and low levels of helpless-hopeless are associated with 
positi ve adjustment. The fighting spirit and helpless/hopeless subscales have been found 
to form a bi-modal scale. In the original principal components analysis the Fighting 
Spirit and Helpless/Hopeless sub-scales contributed to the same dimension in the 
factor analysis; Fighting Spirit items loaded positively and Helpless/Hopeless items 
loaded negatively (Watson et at. , 1 988). When measured separately, these scales 
have been found to be sign ificantl y inversely related (r=-0.46, p<O.Ol ) (Watson et al. 
1988). For the current study, analysis of the reliability of the combined subscale 
indicated good internal consistency (Cronbach's a= 0.93). 
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The fighting spirit subscale has 16 items, including ' I try to keep a very positi ve attitude' 
and ' I try to keep a sense of humour about if . The range of scores for the fighting spirit 
sub cale i 16 to 64. The he lpless-hopeless subscale has six items, including ' I feel Like 
giving up' and 'T feel there is nothing I can do to help myself'. The range of scores for 
the helpless-hopeless subscale is 6 to 24. The scales can be amalgamated by subtracting 
the helpless/hopeless score from the fighting spirit score; a score of more than 12 on the 
helpless/hopeless subscale and less than 47 on the fighting spirit subscale can define 
caseness (Watson et al., 1989). These two sub-scales will be amalgamated and used in 
the current study. 
2.2.5. Satisfaction with Decision Scale (Holmes-Rovner et al. , 1996) 
The Satisfaction with Decision Scale is a five-item scale designed to assess patients' 
satisfaction with general medical decision-making. The scale has been found to have 
good inte rnal consistency (Cronbach's a= 0.86) and be valid when compared to similar 
measures. The scale has also been found to be sensitive to interventions designed to aid 
patient decision-making. Respondents are asked to indicate on a five-point scale whether 
they agree with each item. Example items include: ' I am satisfied with my decision ' and 
'the decision I made was the best decision possible for me persona ll y'. The potential 
range of scores is 5 to 30; the population mean respon e for each item is reported as 3.9 
(s.d. 0.60) (Holmes-Rovner eta/., 1996). 
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participation in Decision-making 
Nominal 
Sutherland et 






In terval Williams 
(1988) 
Patient 's ability to Difficulties in Emotion 
Interva l 
Gratz & 
regulate their distress Regulation Scale Roemer, 2004 
Perception of 
participation in Modified decision-making 
Nominal 
Sutherland et 
decision-making preference statements at. (l989) 
process 
Mental Adjustment to 
P ychological Cancer Scale: Fighting 
Interval 
Watson et al. 
adju tment to cancer Spirit/ Helpless-Hopeless ( I 998) 
Subscale 
Patient' satisfaction 
Satisfaction with Decision 
Holmes-
about their decision- Interval Rovner et al. 
making 
Scale (I 996) 
Table 5: Measures used for individual variables 
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2.3. Participants 
Potential participants for the study were patients auending thei r initial oncology 
outpatient appointment at a district general hospital between October 2008 and June 
2009. This specific sampling time point was chosen, a it is the only consistent point of 
the treatment pathway at which patients are both aware of their diagnosis and expecting 
to make treatment deci sions with the Oncologist. The care pathways for each cancer 
type, from which potential participants were recruited, are included in Appendix 3; 
attendance at the oncology outpatient clinic, where the study was conducted, is 
highlighted for each pathway. There are four outpatient oncology clinics per week at the 
hospital for haematological, breast, gastro-intestinal and colorectal , and lung cancer 
patients. The haematological team declined participation in the research for ethical 
reasons, a diagnosis and treatment decision-making i mo tly completed within the 
same consultation for this cancer site. For all other clinics, patients were aware of their 
diagnosis prior to attendance. 
The three participating clinics, for breast, gastro-intestinal and colorectal , and lung 
cancer pati ents, are each staffed by one oncologist. Approximately 1000 people in the 
region are diagnosed with cancer every year, with an estimated combined incidence of 
576 breast, gastro-intestinal. colorectal and lung cancers. On average, each oncology 
clinic will see approximately 250 new and review patients every ix months. Each clinic 
has three new patient appointments per week. Therefore, within the nine month data 
collection period, there was a maximum potential of 324 new patient appointments 
across all three clinics. 
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Care pathways with in cancer services are heterogeneous. However, all potential 
participants attendi ng the oncology clinic wi ll have received the ir diagnosis and at 
this con ultation been appraised of potential treatment pathways, for example surgery 
followed by chemotherapy, by the diagnosing c linician. They will a lso have been 
referred to a Clinical Nurse Specialist (C.N.S.), whose role is to provide information, 
support and advocacy. Specific information about treatment options, however, for 
example the type of chemotherapy, will not be available until all investigations are 
comple te and reviewed by the Oncologist at the oncology clinic. 
Some patients, a lthough not a ll, may have had surgery prior to meeting with the 
Oncologist. Decisions about surgery are not the subject of the current study; these 
decisions are discussed with the Surgical team, as opposed to the Oncology team, 
most frequently during the diagnostic consultation. As such, thi s was not an 
appropria te sampling time-point. 
The treatment decision-making at the oncology c linic may be about primary 
treatment of the cancer; adjuvant treatment of the cancer after surgery; or pall iative 
treatment of the symptoms caused by the cancer. The treatment options could include 
one or more of radi otherapy; chemotherapy; hormone therapy; or best supportive 
care. Within each treatment choice. there may al so be discussion and decision-
making around the specific type of treatment; the mode of delivery of that treatment 
and the location where the treatment could be delivered. In any deci sion-making 
con ultation, the patient also has the choice to refuse any intervention or treatment. 
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2.3.1. Number of participants required for study 
The software G*Power 3 (Faul et al., 2007) was used for a priori calculation of the 
number of participants required. The calcu lation was based on using logistic regression 
to analyse four predictors of patients achieving their preferred role, the predictors being 
demographic variables, emotion regulation and distress. The a level, that is the 
probability of incorrectly rejecting the null hypothesis, was set at 0.05. The ~ level, that 
it the probability of incorrectly accepting the null hypothesis, was set at 0.2. The 
corresponding level of power was 0.8 therefore, giving an 80% chance of detecting 
existing effects. Based on a medium predicted effect size, the required sample for the 
study was 95 pa1ticipants (Table 6). Due primarily to poor recruitment, and an adverse 
event during recruitment, outlined in the recruitment of participants section (section 
2.3.3), this sample size was not achieved. 
Required power 
Alpha level Effect size (f) 
Required sample 
<1~Jn size 
0.80 0.05 Small (0.02) 676 
0.80 0.05 Medium (0.15) 95 
0.80 0.05 Large (0.35) 44 
Table 6: A priori sample size calculation using G*power 3 (Faul et al., 2007) 
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2.3.2. Inclusion and exclusion criteria 
Inc lusion and exclusion criteria were applied to ensure the suitability of partic ipants. The 
following inclusion criteria were used in the selection of potential participants: 
l . Persons with a definite diagnosis of malignant cancer; 
2. Persons attending a fi rst oncology outpatient appointment for the current episode of 
care; 
3. Persons aged over 18 years; 
4. Persons with the ability to understand and write English, to the level of being able to 
complete study materials; 
5. Petmission to contact person granted by the medical team. 
Similarly, the following exclusion criteria were used in the selection of potential 
participants: 
I . Pe rsons at e nd stage of illness (prognosis <6 months); 
2. Persons under the age of 18 years; 
3. Persons diagnosed with non-malignant tumour; 
4. Persons who have previously attended an oncology outpatient appointment for the 
current episode of care; 
5. Persons who have requested not to be approached for research purposes; 
6. Permission to contact not gained or granted by the medical team. 
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2.3.3. Recruitment of participants 
Potential participants for the study were identified from clinic lists. The suitability of 
potential participants for the study was discussed with the medical team and permission 
was sought to send study information. The researcher also attended three weekly multi-
disciplinary meetings in order to be aware of any late changes to changes to clinic 
arrangements. Reasons for the medical team not granting permission to contact patients 
included the physical well-being of the patient and not knowing the individual patient's 
circumstances. Seventy two possible participants were identified of which, 26 agreed to 
participate. 
During the study period, one oncology clinic was closed due to extraneous 
ci rcumstance , reducing locally held clinics to two. Patients from the closed clinic were 
required to attend an oncology clinic at a cancer centre in different region and it was no 
longer possible to recruit this population to the current study. Other challenges to the 
recruitment process included the medical team being unavailable to grant permission to 
contact patients, and low numbers of patients meeting inclusion criteria. Given 
significant ethical concerns regarding approaching patients prior to their being aware 
treatment decisions may be required, the protocol could not be extended to include 
review patients. which may have increased recruitment. Therefore, due to the poor 
recruitment to the study, the statistical analysis was altered. This i di cussed in the 
statistical analysis section (section 2.5). 
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2.4. Study procedure 
The study procedure is ilJustrated in Figure 6. Following identification of potential 
participants, outlined in section 2.3.3, study information was sent by post. The study 
information, included in Appendix 4, outlined the purpose and procedure of the study. 
The researcher then approached potential participants while they waited for their 
oncology outpatient appointment, to enquire whether they would like to participate. 
Reasons fo r not participating were not requested following discussion with the ethics 
committee. 
If wishing to participate, patients were asked to complete a consent form and given the 
fi rst questionnaire to complete prior to their consultation. The first questionnaire 
included: 
• Socio-demographic questionnaire including gender, age and occupation 
• General Health Questionnaire 12 (Goldberg & Williams, 1988) 
• Decision-making preference statements (Sutherland et a/. , 1989) 
Participants were also given the second questionnai re to be returned by post. Information 
about local support services was included with this questionnaire. The second 
questionnaire included: 
• Modified Decision-making statements (Sutherland eta/., 1989) 
• Difficulties in Emotion Regulation Questionnaire (Gratz & Roemer, 2004) 
• Mental Adjustment to Cancer: Fighting Spirit/Helpless-Hopeless Sub-Scale (Watson 
era/., 1988) 
• Satisfaction with Decision Scale (Holmes-Rovner et al., 1996) 
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Descriptions of the measures used and information about the psychometric properties are 
detailed in section 2.2. Three months after attending the oncology clinic, participants 
were posted a follow up questionnaire to be returned by post. The final questionnaires 
included: 
• Mental Adjustment to Cancer: Fighting Spirit/Helpless-Hopeless Sub-Scale (Watson 
et al., 1988) 
• Satisfaction with Decision Scale (Holmes-Rovner et al. , 1996) 
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Patient attending oncology clinic for first time identi fied from clinic li st I 
~ 
Inclusion and exclusion criteria applied ; pennission given to contact 
+ 
Potential partic ipants sent information leaflet by post prior to first 
appointment with oncology clinic. 
~ 
Patients approached while waiting at c linic by researcher (n=72) 
~ 
Participants recruited (n=26) 
Identifier assigned to questionnaires and consent form 
+ 
Pre consultation, patients asked to comple te questionnaire set one 
(n=26) 
l 
Post consultation patients asked to comple te que tionnaire e t two and 
return by post (n=26) 
3 months late r patients posted questionnaire set three to comple te and return 
by post (n= 13) 
Analysis of res ults 
Res ults written for thesis. 
Results disseminated locally 
Figure 6: Flowchart of procedure 
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2.5. Statistical analysis 
The collected data were entered anonymously into a SPSSTM 14.0 database for analysis. 
The measurement of the main variables was described usi ng descriptive statistics. For 
the inferential statistics the significance level was set at p<0.05. Although the alternative 
and null hypotheses were directional, where appropriate, two-tailed tests were used. The 
reason for this was to allow consideration of any results in an unexpected direction. The 
data were first tested, to estab]jsh whether they met assumptions for parametric testing. 
The planned analysis of the data in respect to the hypotheses is outlined below. 
It was planned to explore the first two hypotheses, looking at distress and participants' 
preference for, and their perception of their actual, participation in treatment decision-
making, using one-way ANOV A, and subsequent three post-hoc pair wise comparisons 
between groups. However, due to small sample size it was not possible to establish the 
data for each group were normally distlibuted or had homogeneity of variance. 
Therefore, a Kruskal-Wallis test was used to establish whether the groups differed. 
Using the BonferToni correction, the a level for the post-hoc Mann-Whitney tests was set 
at p<0.02. 
For the main three hypotheses, looking at distress, emotion regulation and attainment of 
preferred role in treatment decision-making, it was planned to use a logistic regression 
model , with four predictors: age, gender, distress and emotion regulation. However, 
given the smaller sample size, si mple correlation analysis was used to explore 
associations between the variables instead. 
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For the final two hypotheses looking at the attainment of preferred role in treatment 
decision-making and psychosocial outcomes, it wa intended to use a repeated measures 
ANOYA to explore the effect of time and group. However, gi ven attrition at three month 
follow up, independent sample t-tests were used to explore the di fferences between 
participants who had attained their prefeiTed role and those who had not. 
Outside the study hypotheses, some exploratory data analysis was also canied out. 
Weinberg & Abramowitz (2009, p.xiii) comment: "Seeing a three-dimensional sculpture 
in its entirety requires viewing that sculpture from many vantage points. Likewise, fully 
under tanding the phenomenon under study often requires delving into data from more 
than one vantage point" Exploratory data analysis was used to look at sub-scales of the 
measures used. comparing sample means to the general population, and looking at the 
relationship between the repeated measure variables. 
2.6. Ethical considerations 
In line with British Psychological Society guidelines (2004, 2005) and government 
policy (Scottish Executive, 2006), ethical approval and advice for conducting the current 
study was sought and received from the NHS Research and Ethics Committee. In 
addition. approval from the local Research and Development Committee was sought and 
received. Specific ethical issues discussed with the ethics committee are outlined in 
. ection 2.6. 1. Documents outlining ethical approval are included in Appendix I . 
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2.6.1. Specific ethical issues 
Several specific ethical issues were addressed in the ethical application or wil h the 
ethical committee. It was acknowledged that potential participants would be in the early 
stages of adjustment to a serious illness, and as such may be experienced elevated levels 
of distress. The fundamental nature of the study questioned the impact of patient distress 
levels on their ability to pa1ticipate in decision-making. It was recognised that this issue 
may also be applicable to the process of potential patticipants giving informed consent 
for the study. In order to address this, specific permission was sought from the medical 
team prior to contacting potential participants, who were then all provided with study 
information the week prior to attending their clinic appoi ntment. The information 
included the option for participants to inform staff if they did not wish to be approached 
for recruitment purposes. It was also agreed with the ethical committee not to enquire as 
to why potential participants may have refrained from the study or gather any 
information about them. 
The research questionnaires directly questioned issues of emotional well-being and 
adjustment. Therefore, it was also acknowledged that the study a) had the potential to 
increase patient awareness of their emotional well-being and b) identify individuals 
suffering clinically significant levels of distress. In order to safeguard patticipant from 
unnecessary distress, information was provided about two local support services: the 
cancer information and supp01t service and the psycho-oncology service. Further, the 
study info rmation explicitl y stated that if the researcher, an individual with training in 
identifying and managing distress, had concems regm·ding the safety of participants or 
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that of another, information would be passed on. In this case, the participant would be 
contacted by the researcher to discuss, in more detail, the concern raised. 
Associated with this, the study information emphasised that responses to the study were 
confidential , and that outwith exceptionaJ circumstances the participant's medical team 
would not be informed of their response. All questionnaires and associated consent 
forms were assigned an identifier to allow anonymity. Questionnaires and consent forms 
will be stored separately and securely on NHS premises for four years, in accordance 
with research governance guidelines, and subsequently destroyed as confidential waste. 
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3. CHAPTER THREE: RESULTS 
3.1. Participants 
Of the 72 potential participants approached, 26 participants were recruited to the study 
(36.11% response rate). Demographic characteristics of the participants are described in 
Table 7. Participants were aged between 46 and 82 years, with a mean age of 63.02 
years; the majority were female (84.62%); retired (73.08%) and the majority had a 
diagnosis of breast cancer (73.08% ). 
Demographic Characteristic 
F requency (n=26) 
N= (%) 
Age 45-54 7 (26.92%) 
55-64 6 (23 .08%) 
65-74 9 (34.62%) 
Over 75 4 (15.38%) 
Gender Female 22 (84.62%) 
Male 4 (15.38%) 
Occupation Retired 19 (73 .08%) 
Unskilled work 1 (3.85%) 
Semi-skilled work 4 (15.38%) 
Skilled work 2 (7.69%) 
Cancer Site Breast 19 (73.08%) 
Gastro-intestinaVColorectal 3 (11.54%) 
Lung 4 (15.38%) 
Table 7: Demographic characteristics of participants in study 
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3.1.1. Reported preference for participation and actual participation in 
treatment decision-making 
Participants repotted varied prefere nces for participation in treatment decision-making 
(Table 8). Half of the sample (n= 13) indicated that they would prefer shared decision-
making; 34.62% (n=9) indicated they would prefer to be pass.ive in decision-making and 
the smallest proportion, 15.38% (n=4), indicated they would prefer to be active in 
decision-making. 
Actual Level of Participation 
Passive Shared Active Total {pref) 
N= N= N= N=(%) 
Passive 
8 0 1 9 (34.62%) 
N= 
Preferred 
Shared Level of 
N= 




I 0 3 4 (15.38%) 
Total 
(actual) 13 (50%) 7 (26.92%) 6 (23.08%) 
N=(%) 
Table 8: Patient preferred and actual roles in treatment decision-making 
Ha lf of the sample (n= 13) repotted that they took a passive role in decision-making, 
26.92% (n=7) indicated that the decision-making was shared and 23 .08% (n=6) indicated 
they were active in decision-making (Table 8). Overall, eight participants (30.77%) did 
not attain the role that they had preferred in treatment dec ision-making consultation 
(Table 8); 11.54% (n=3) were more acti ve in the decision-making than prefetTed and 
19.23% (n=5) were more passive than preferred. 
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3.2. Descriptive statistics for the main variables 
The descriptive statistics for the main variables are shown in Table 9. Three participants 
did not complete the second set of questionnaires sufficiently, and were therefore 
excluded from certain analyses. On average participants scored 15.92 (s.d. 6.26) on the 
GHQ-12. 73.08% (n= 19) of pruticipants scored above the clinical cut-off for this 
measure of distress. For the Difficulties with Emotion Regulation Scale, the mean score 
was 63.42 (s.d.l8.80); a one sample t-test found that this was a significantly lower score 
compared to the population mean (M=79.33, s.d.: 19.76) reported by Gratz and Roemer 
(2004), indicating that the current study's participants had fewer difficulties with 
emotion regulation; t(378)=3.75, p<0.01, r=0.19. 
On average, participants scores for the Fighting Spirit/Helpless-Hopeless scale increased 
from immediately after the time of the consultation (M=45.57, s.d. 7.34) to the three 
month follow up (M=50.18, s.d. 4.33). Similarly, participants scores for the Satisfaction 
with Decision Scale increased from immediately after the time of the consultation 
(M=25.52, s.d. 3.45) to the three month follow up (M=26.82, s.d.2.48). The mean score 
for an item on the Satisfaction with Decision Scale was 4.25 at the consultation and 4.47 
at the three month follow up. 
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Measure Range Mean S.D. Z skcwncss Zkurtosis 
General Health 
Questionnaire - 12 7-27 15.92 6.26 0.58 -1.04 
(n=26) 
Difficulties with 
Emotion Regulation 39-108 63.42 18.80 1.98 0.06 
(n=23) 
Fighting Spirit/ 
Helpless-Hopeless 33-57 45.57 7.34 0.17 -0.99 
(n=23) 
Fighting Spirit/ 
Helpless-Hopeless - 45-58 50.18 4.33 0.62 -0.16 
follow up (n=13) 
Satisfaction with 
19-30 25.52 3.45 0.19 -1.11 
Decision Scale (n=23) 
Satisfaction with 
Decision Scale -follow 23-30 26.82 2.48 0.09 -0.97 
up (n=13) 
Table 9: Descriptive statistics for main variables 
3.3. Exploration of assumptions for parametric tests 
In order to use parametric statistical tests for analysis to answer the hypotheses, the study 
data were required to meet four assumptions (Field, 2009). The assumptions of 
parametric tests are a) the data are normally distributed; b) the data have homogeneity of 
variance; c) the data are at interval level and d) any between-subject data are 
independent. 
To assess whether overall the data were normally distributed, the skewness (the 
symmetry of the distlibution) and kurtosis (over or under population of the tails of the 
distribution) of the data were calculated. For considering the impact of data' s skewness 
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and kurtosis, Miles and Shev lin (200 1) recommend that z-scores greater than 2.0 indicate 
that there is cause for concern about the validity of any statist ical tests. This 
recommendation is in line with other authors (Weinberg & Abramowitz. 2009). Overall, 
the z- cores for all the measures are less than 2.0 (Table 9). P-P plots and histograms for 
each vari able are displayed in Appendix 5. 
In order to answer each hypothesis, valious groupings of participants were investigated; 
therefore, the data for each group was considered in relation to the assumptions required 
for parametlic tests. For the first two hypotheses, the data was considered in groups 
based on patient preference and actual participation in decision-making. In smaller 
·ample . the power of the tests used to assess whether the data meets parametlic 
assumpt ions is reduced. For the most part, each group had less than ten participants, 
therefore, the data could not be adequately tested and accepted as meeting the 
assumptions required for pararnetlic testing. Given this, non-parametric statistical 
analysis was used for these analyses. 
For the remaining hypotheses, the data was considered in two groups, fanned by a 
categori cal variable: whether patients matched their preferred role in decision-making or 
not. The calculated z-scores for the skewness and kurtosis of the main variables are 
shown in Table I 0 and Table 12. The distributions of the data for the groups were not 
sign ificantly di fferent to normal. An exploration of the data's homogeneity of valiance is 
displayed in Appendix 5. 
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3.4. Patient distress and preference for participation in treatment decision-
making 
The role in decision-making that participants identified as preferring was compared to 
levels of distress. Figure 7 shows that pa1ticipants reporting preferring a shared role in 
treatment decision-making had the lowest median score on the GHQ-12 (Mdn = 16.00), 
compared to participants reporting preferring a passive (Mdn = 13.00) or active role 
(Mdn = 15.00). A Kruskaii-Wall is test, however, showed that there was no significant 













"' "' b Il l 
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Passive nc9 Shared n• l3 Act ive n;;t 
Role preferred in treatment decision-making 
Figure 7: Box plot showing median distress by role preferred in treatment decision-making. 
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3.5. Patient distress and participation in treatment decision-making 
The role participants perceived they had taken in treatment decision-making was 
compared to levels of distress. Figure 8shows that participants reporting a passive role in 
treatment decision-making had the higher median score on the GHQ-12 (Mdn = 1 7.00), 
compared to patt icipants reporting a shared role (Mdn = 10.00), but not compared to 
participants reporting an active role (Mdn = 17.00) 
30 
~· 20 
"' "' ~ 10 
! 
Passive n• l3 Shared n- 7 
Role taken in treatment decision-making 
Active n--6 
Figure 8: Box plot showing distress by role taken in treatment decision-making 
A Kruskal-Wallis test showed that distress was significantly related to actual role in 
treatment decision-making, H(2) = 9.97, p<O.O I. Post-hoc Mann-Whitney test 
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comparisons showed that participants reporting a passive role had significantly higher 
distress (Mdn = 17.00) than those reporting a shared role (Mdn=l0.00), U = 6.50, z = 
3.10, p<O.Ol , r= 0.69 (Figure 9), but not an active role (Mdn = 17.00), U = 29.00, z = 
0.89, n.s., r = 0.20. Participants taking an active role also had higher distress than those 






Figure 9: Calculation of post-hoc Mann-Whitney test effect size 
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3.6. Distress and attainment of preferred level of participation in treatment 
decision-making 
Descriptive statistics, for participants who perceived that they took their preferred role in 
treatment decision-making and those who did not, are shown in Table 10. 
Role taken matched Role taken did not match 
preference (n=l8) preference (n-8) 
Age Mean: 63.56, s.d.= 11.01 Mean: 61.88, s.d.= 14.88 
Gender Male 2(11.11%) 2 (25%) 
Female 16 (88.89%) 6 (75%) 
Cancer Site Breast 14 (77.78%) 5 (62.5 %) 
GI & Colorectal 2(11.1 1%) 1 (12.5%) 
Lung 2 ( II.)] %) 2 (25%) 
Mean 13.44 19.75 
S.D. 5.10 5.29 
Distress 
Zskewncss 0.50 0.80 
Zkunosis -0.78 0.03 
Mean 58.47 75.43 
Emotion S.D. 13.23 25.50 
ReguJation Zskewnes.~ 1.37 0.10 
zkltnOSiS 0 .. 06 -0.41 
Table 10: Descriptive statistics for participants wbo attained and did not attain preferred role in 
decision-making 
There was no significant association between gender and whether a participant had 
attained their preferred role in decision-making, rq>=-0.18, p=0.37, n.s .. There was also 
no significant association between participants' age and attai ning their preferred role in 
decision-making, rpb=-0.07, p=0.75, n.s .. 
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The relationship between participant distress and matching of the preferred and actual 
role was investigated using point-biserial correlation. On average, participants who 
perceived that their actual role in treatment decision-making matched their preferred role 
had lower distress (M = 13.44, s.d.= 5.1 0), compared to participants whose actual role 
did not match their preferred role (M = 19.75, s.d.= 5.29) (Figure 10). There was a 
significant relationship between participant distress and whether they attained their 
preferred role in treatment decision-making, rpb = 0.51 , p<O.O I. This suggests that 








Matched. n= 18 Unmatched. n=8 
P referred and actua l role in treatment decision making: matched or unmatched 
Figure 10: Box plot graph showing distress and attainment of preferred role in treatment 
decision-making. Central tendency shown is the median. 
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3.7. Emotion regulation and attainment of preferred level of participation in 
treatment decision-making 
The relationship between difficulties with emotion regulation and reported attainment of 
preferred role was investigated using point-biserial correlation. On average, participants 
whose actual role in treatment decision-making matched their preferred role had lower 
ratings on the Difficulties with Emotion Regulation Scale (M = 58.47, s.d.= 13.23), 
compared to participants whose actual role did not match their preferred role (M = 75.43, 
s.d.= 25.50) (Figure I I). Higher scores on the scale indicate greater di fficulty with 
emotion regulation. There was a significant relationship between emotion regulation and 
whether participants reported achieving their preferred role in treatment decision-
maki ng, r pb = 0.42, p<0.05. This suggests that emotion regulation can account for 


























Mmched, n= 17 Unmatched. n= 7 
Preferred role and actual role matched: matched or unmatched 
Figure Ll: Box plot graph showing emotion regulation and attainment of preferred role in 
treatment decision-making. Central tendency shown is the median. 
From a theoretical perspective, a person's emotion regulation abi lity moderates distress 
to allow a person to achieve goals. In the current sample, for patticipants who attained 
their preferred role in treatment decision-making, distress showed no association with 
emotion regulation, r=O.OS , p=0.86, n.s .. However, for participants who did not attain 
their preferred role in treatment decision-making, higher distress showed a non-
significant positive association with greater difficulty in emotion regulation , r=0.62, 
p=0.1 3, n.s .. 
In order to test the hypothesis in the current setting, a partial zero-order cotTelation was 
carried out. Distress was not significantly related to whether a participant attained their 
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preferred role in treatment decision-making, when emotion regulation was controlled for, 
r pb = 0.33, ns, now accounting for 10.89% of the variance. This suggests a more complex 
re lationship between distress; emotion regulation; and whether a person takes their 
preferred role in treatment decision-making consultations. 
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3.8. Exploratory analysis of Difficulties with Emotion Regulation Scale sub-
scales 
The Difficulties with Emotion Regulation Scale has s ix sub-scales, each measuring 
different aspects of emotion regu lation . To explore whether there were any significant 
differences between participants who did, and did not, attain their preferred role in 
decision-making, point-biserial correlations were carried out. No subscale significantly 
accounted for any variance in whether a participant attained their preferred role in 









Correlation rpb=0.13, rpb=0.23, rpb=0.37, rpb=0.25, rpb=0.18, rpb=0.30, 
coefficient p=0.58, p=0.23, p=0.09, p=0.27 , p=0.44, p=0.17, 
n..s. n.s. n..s. n..s. n..s. n.s. 
Table 11: Point biserial cor relation for DERS subscales and patient attainment of role 
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3.9. Attainment of preferred role in treatment decision-making and psycho-
social outcomes 
In order to investigate the effect of participants attaining their preferred role in treatment 
decision-making on their continued psychological adjustment and satisfaction with the 
decision, independent sample t-tests were carried out. The average scores for each group 
of participants on the psychological adjustment and satisfaction outcome measures is 
summarised in Table 12. 
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Measure 
Actual role matched Actual role DID NOT 
preferred role match preferred role 
Mean 45.81 45.00 
Fighting Spirit/ S.D. 7.07 8.47 
Helpless-Hopeless 
(n=23) Z skewness 1.22 -0.66 
Zkunosi;. -1.61 -0.32 
Mean 46.44 51.50 
Fighting Spirit/ 
S.D. 8.95 4.43 
Helpless-Hopeless -
Zskewness -1.82 -1.72 follow up (n=l3) 
Zkunosis 1.97 1.58 
Mean 24.94 26.86 
S.D. 3.55 3.02 
Satisfaction with 
Decision Scale (n=23) Z skewness 1.53 0.56 
Zkunosis -0.60 -1 .27 
Mean 26.22 
26.75 
Satisfaction with S.D. 2.95 2.75 
Decision Scale -follow 
up (n=13) Z skcwness -0.60 0.32 
Zkurtosis -0.7 J -1.15 
Table 12: Descriptive statistics of psychosocial outcome measures 
There were no significant differences between those who had attained their preferred 
role and those who had not, for satisfaction with their decision or psychological 
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r(21) = 0.24, t( ll )= 1.06, t( ll) = 0.30, 
actual role: t(21) = 1.24, ns, 
matched or p=0.23, ns, r = p=0.31 ns, r = r = 0.26 p=0.77, ns, r = 
unmatched 
0.05 0.30 0.09 
Table 13: Independent sample t-tests to compare psychosocial outcomes 
Exploratory data analysis showed that, for all participants together, scores fo r positive 
psychological adjustment at follow up (M=48.00, s.d.= 8.01) were not significantl y 
higher than at the time of consultation (M=45.56 s.d.= 7.34), t( l2)=2.04, p=0.06, n.s., 
r=O.SO. There was also no significant difference for overall scores for satisfaction with 
decision from consultation (M=25.52, s.d.=3.45) to fo llow up (M=26.38, s.d.=2.79), 
t(l2)=1.73, p=0.13, n.s., r=0.45. 
Exploratory Kruskal-Wallis tests found no significant association between participants' 
actual level of participation in treatment decision-making (active, shared or passive) and 
psychological adj ustment immediately following the consultation, H(2) = 0.20, p = 0.91 , 
n.s. or at three month follow up, H(2) = 1.46, p = 0.48, n.s .. Nor any association between 
actual pa11icipation in treatment decision-making and satisfaction with decision made, at 
the time of consultation, H(2) = 1.46, p = 0.48, n.s, or at three month follow up, H(2) = 
0.72, p = 0.70, n.s .. 
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4. CHAPTER FOUR: DISCUSSION 
4.1. Overview of findings 
The current tudy looked at patient participation in treatment decision-making for 
cancer. Its primary aims were to explore the how distress is associated with this process, 
and whether participating in treatment decision-making affects patients' psychosocial 
outcomes. 
Patients preferred varying levels of participation in treatment decision-making 
consultations. with the majority preferring a shared role. Ba ed on previous research, it 
was hypothesised that high levels of distress would be as ociated with a preference for a 
pa si ve role in treatment decision-making, with the doctor making the treatment 
decision. In fact, no association was found between distress and patient preference for 
participation. 
The most prevalent role assumed during treatment decision-making was passive. Again, 
it was hypothesised that high levels of distress would be associated with patients taking a 
passive role in treatment decision-making. The study findings showed partial support for 
this hypothesis. Significantly higher levels of distress were associated with patient 
taking a pa sive role, but distress was also elevated. albeit not significantly, in patients 
taking an active role. as the main decision maker. This ugge ts that patient di tress does 
not always hinder participation in decision-making. 
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However, the hypothesis, that higher distress would be as ociated with patients not 
achieving the level of participation they preferred. was supported by the findings. 
Furthermore, greater difficulty with emotion regulation was also associated with this, 
and in line with the experi mental hypothesis, emotion regulation moderated the 
a sociation that distress had with patients achieving the level of participation they 
preferred. 
The final hypotheses were that patients achieving their preferred role in treatment 
decision-making would have better psychosocial outcomes, that is psychological 
adjustmem and satisfaction with the decision made. The study findings did not support 
this hypothesis: concordance with preferred role in treatment decision-making was not 
found to be significantly related to psychosocial outcomes. 
Thi fi nal chapter considers each of the research question in tum, and detai ls the study 
findings in answeri ng each one, as well as, comparing the findings to the previous 
literature. Fol lowing this, the strengths and limitations of the study are discussed, and the 
potential cli nical and policy implications of the findings are outlined. 
4.1.1 . Preference for participation in treatment decision-making 
The participants in the study reported varying preferences for partic ipating in treatment 
decision-making. Exactly half of the sample reported to pre fer a shared role in treatment 
decision-making and just over one third preferred a passive role with le s than one sixth 
an active role. In line with previous studies, summarized in section 1.4, the findings 
illustrate that the shift in health policy, toward encouraging patients to be more actively 
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involved in their health care, does not correspond to a universal patient preference for 
participating in oncology treatment decisions. Given this, it would be useful to 
understand further which patients want to be involved and why; how we can faciHtate 
participation when it is desired and whether participating has an effect on patient 
outcomes. 
Contrary to experimental hypothesis, the study found no significant relationship between 
di stress and participants' preferred level of participation in treatment decision-making. 
Previous qualitative research has found that patients often c ite emotional distress as 
affecting their desire to participate (Cohen & Britten, 2003; Kenny et al., 1999). Vogel et 
at. (2008) found that people who had higher levels of depres ion were more likely to 
prefer a pas ive role in decision-making. In contrast, similarly to the current study Wong 
et al. (2000) and Janz er al. (2004) also did not find a significant association between 
present mood and preferences for participation. 
On average, participants in the study by Vogel et al. (2008) were below the clinical cut 
off for anxiety and depression; in comparison, a significant proportion of the participants 
in the cun·ent study were above the clinical cut-off for distress. Of note, participants in 
the study by Vogel et al. (2008) had a lready started treatment at the time of completing 
the measure of mood, whkh may have reduced any distress associated with uncertainty 
around this time. Therefore, perhaps, the current study's finding indicates that, at times 
of heightened distress, there is no association between distress and patient preferences 
for participating in treatment decision-making. 
112 
In fact, despite the abundance of research, over the past 20 years, into patient preferences 
for participation in treatment decision-making, few variables have been consistently 
found to account for significant proportions of variance in individual preferences. 
Previous research has established a trend that younger, female patients prefer greater 
patticipation; however, these demographic characteristics account for only a small 
proportion of the variance in preferences for participation (Degner & Sloan, 1992). It is 
also possible, however, that demographic variables co-occur with other factors that may 
have a more substantial influence on patients' preferences, such as attitudes about health 
care professionals, or tbe prognosis of illness. 
Themes emerging frequently in qualitative research centre upon practical concepts, such 
as expertise and knowledge; cultural concepts, such as attitude towards doctors; and intra 
and inter personal concepts, such as anxiety, trust and attribution of responsibility. The 
frequent repJjcation of the finding that preferences for participation are not stable, and 
can change over the course of a person's treatment, strong! y indicates that a preference is 
not a static charactetistic but rather a product of a number of factors (Malinger et al., 
2006; Degner et al., 1997). However, the evidence from quantitative studies so far, 
including the current study, provides little support that a patient's current emotional 
well-being is likely to be a central determining factor. 
4.1.2. Actual participation in treatment decision-making 
The participants in this study reported varying levels of participation in treatment 
decision-making; exactly half of the pmticipants reported having a passive role; just over 
a quatter repotied that the decision-making was shared; and just under a quarter repotted 
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that they had made the decision. These findings are in line with the existing research 
body, which has found wide ranging reports of participation. indicating that shared 
decision-making happens in between 12% and 30% of cases (Fischer et at., 2006; Vogel 
et at., 2008). The discrepancy between the dominant model of shared decision-making 
and the finding that patients often taking a passive ro le in treatment decision-making 
begets a question about what factors influences the level of patient participation in 
treatment decision-making. 
For the current study, a strong, significant effect was found for reported participation in 
re lati on to levels of distress; however, this was not a simple relationship. It was 
hypothesised that higher levels of distress would be associated with less participation in 
the consultation. A shared role in treatment decision-making was associated with the 
lowest level of di stre s. However, distress was significantly elevated in people reporting 
both a passive or active role. On average, the level of distress for people reporting a 
passive or acti ve ro le was above the clinical cut-off, whereas on average those taking a 
shared role reported distress below the clinical cut-off. 
This finding is in contrast to previous quantitative studies, which have not established a 
significant re lationship between a patient 's distress and their pa1ticipation in treatment 
decision-making. Unlike the current study, the previous work has focused on depression 
as an index of distress. and all previous studies have relied on ret rospecti ve measurement 
(Hack et at., 1994, Sainio & Lauri , 2001). The cur rent study measured generic distress as 
opposed to a specific constellation of symptoms, and correlated mood at the time of the 
consultation with the ro le that participants took. From this perspective, the current 
study's findings can be considered credible. It is recognised, however, that this finding is 
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based on a small sample, using univariate analysis only, which may limit inferences that 
can be drawn at this stage. Therefore, the current finding does provide some modest 
evidence that a patient's distress is associated with their level of participation in 
decision-making. 
Although a person 's level of distress was not associated with their preference for 
participation in decision-making, it was found to be signifi cantly associated with their 
actual participation in decision-making. This is congruent with the Communication 
M odel of Decision-making, that emotion impacts upon the communication climate 
(Siminoff & Stepp, 2005). However, this leads to the question of how a person's distress 
affects the deci ion-making process, and whether being distressed is impeding patients' 
ability to be involved in treatment decision-making to the extent they would prefer. 
4.1.3. Patient distress and attainment of preferred role in treatment 
decision-making 
Nearly one third of the participants in the study did not attain the level of participation in 
treatment decision-making that they had indicated they would prefer. This was a 
relati vely small proportion in comparison to previous research, which has found a lack of 
concordance in anything from 20% to 75% of cases (Gatellari er at. , 2001; Lam et al. , 
2003). There was a strong relationship between the level of distress pa1ticipants reported 
and whether they attained their preferred level of participation in treatment decision-
making; participants who did not attain their preferred role in decision-making reported 
higher distress. No previous study in oncology has explored the association of distress 
with patients achieving a preferred role in treatment decision-making. Government 
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guidance specifically recommends that patient with cancer should be involved in 
treatment decisions to the extent they prefer (NICE, 2002). In line with this, outcome 
research is beginning to suggest that a person achieving their preferred level of 
participation, rather than their actual level of participation, may lead to improved 
psychosocial outcomes (Hack et al., 2006; Lantz et at., 2005 K eating et al., 2006). 
Consideration of the mechanisms that influence a person's participation in decision-
making, therefore, is key in establishing strategies to support patients. The current 
study's finding suggests that patient distress may be a maj or influence to consider, when 
understanding these mechanisms. 
The di crepant findings that distress is associated with a person's actual role in treatment 
deci ion-making but not their preferred role reflect the arguments of Loewenstein 
(2005), who suggests that emotion can affect people' behaviour. often beyond their own 
prediction. The current study's findings are in keeping with theoretical understanding of 
emotion and decision-making, which suggests that emoti on can interfere with normative 
decision-making (Winkleman eta/. , 2007). As the current study used univariate analysis, 
we cannot predict causal direction from the statistical analysis; however, gi ven that 
distress was measured at the time of the consu ltation, it wou ld seem reasonable to 
conclude that distress could interfere with patients' interaction with their doctor. 
Consultations about treatment decision-making may include further test results, a choice 
between unattractive alternative courses of care, and the delivery of complex 
information, all of which may exacerbate negati ve emotion while simultaneously 
requiring the person's deliberation. 
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4.1.4. Emotion regulation and participation in treatment decision-making 
Participants who did not attain their preferred role reported greater difficulties in 
emotion regulation; this was indicative of a moderate, statisti cally significant 
relationship. No previous sn1dies have directl y looked at the relationship between a 
person's ability to regulate their emotions and participation in medical decision-making. 
However, there are some previous studies, which can be considered alongside the current 
finding. 
The current findings are in )joe with the study by Collie et a/. (2005) which found that 
sel f-efficacy for affect regulation was as ociated with less problematic medical 
encounters for women with breast cancer; certainly achieving the level of participation 
preferred in a consultation may be akin to a less problematic consultation. Two studies 
have looked more speci fically at patient participation in medical decision-making and its 
association with patient coping strategies. Fischer et a/. (2006) failed to find an 
association between people who habitually used problem-focused coping and taking an 
active role in decision-making, however, Hack et al. ( 1994) found that people who were 
avoidant were more likely to prefer a passive role. The distinction that Gross (1 999) 
makes between coping and emotion regulation, is that emotion regulation is an 
immediate and dynamic modulation of the emotional response, whereas coping includes 
habitual or dispositional behaviour strategies that may not olely be focused on emotion. 
Therefore, perhaps habitual coping strategies are associated with people's preferred or 
intended role in decision-making, such as shown by Hack et al. ( 1994) but are 
in ·ufficient to account for their real time actions under stress, such as shown by Fischer 
et at. (2006). 
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Level of distress are evidently raised at the time when oncology treatment decisions for 
cancer are made; the majority of the participants in the current srudy scored above the 
clinical cut-off on the measure of distress. However, in spite of thi s, the majority of the 
participants did attain their preferred role. It was proposed that emotion regulation 
moderates the relationship between distress and pruticipation in treatment decision-
making. The current results go someway to supporting this. A partial correlation showed 
that the unique contribution of a patient's distress in explaining variance in their 
achieving their preferred role in decision-making was reduced from 26% to 10%, when 
accounting for their emotion regulation ability. In order to explore this model further, 
these relationships need to be considered multivariately, which is beyond the scope of 
thi study. Of course, other factors may also moderate the impact a patient's distress, 
such a the doctor's consultation style and social support, which would need to be 
considered in further research. 
Theories of emotion regulation propose that emotion regulation strategies are used to 
guide our behaviour towards goals, increasing emotional responses that promote useful 
behaviour and decreasing emotional responses that promote ineffectual behaviour 
(Gross, 1998). For patients with cancer, when the goal is participating in treatment 
decision-making, it is suggested that their emotion regulation strategies facilitate or 
impede their ability to do so, by moderating the impact of thei r distress. 
In order to begin to look further at which mechanisms of emotion regulation may be 
associated with a person achieving their preferred role, exploratory data analysis of the 
subscales of the Difficu lties in Emotion Regulation Scale was carried out. No significant 
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differences were found between participants who did and did not attai n the level of 
participation that they had preferred. The lack of signi ficant differences between the two 
groups gives rise to two potential suppositions; firstly, that a cumulative deficit in 
emotion regulation strategies leads to weakened control over responses; or a significant 
effect in specific mechanisms was missed in this smaller study. 
4.1.5. Patient participation in decision-making, satisfaction with decision 
and psychological adjustment to cancer 
A concordance between preferred and actual role in treatment decision-making was not 
found to be significantly associated with satisfaction with the decision made, or 
p ychological adjustment. This relationship was not significant immediately following 
the decision, or at three month follow up. 
Previous research has found that active or shared participation in treatment decision-
making leads to better satisfaction with the decision (Keating et al., 2006; Fischer er al., 
2006), and better psychological adjustment (Deadman et at. , 200 I; Fa llowfield et al., 
1994). Other studies have further argued that, regardless of the actual level of 
participation, achieving a preferred level of participation leads to improved outcomes. 
The current study does not provide support for this argument. Exploratory data analysis 
also did not show support for previous research indicating that a shared or active ro le led 
to improved outcomes. 
The current study's three month follow up was a imilar length of time to follow up in 
previous studies investigating patient satisfaction with decision-making (Keating et al., 
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2006). However, whereas previous studies employed a imple Likert cale to measure 
participant satisfaction, the current study employed a validated tool (Holmes-Rovner et 
a/., 1996). While both these factors may support the credibility of the current study, the 
mall quantity of follow up data of the current study (n= 13) limits the robustness and 
ability to make inferences from these findings. 
For psychological adjustment, the three month fol low up was significantly shorter than 
some of the previous studies (Fallowfield et at., 1994; Hack et a/., 2006), and the sample 
size considerably smaller. Therefore, caution is required in accepting the current finding 
that no significant relationship exists between participati on in treatment decision-making 
and psychological adjustment, as the study may not have been sufficiently powerful to 
detect an effect. The limitations of the study are further discussed in section 4.2. 
The focus of research on treatment decision-making has been motivated by health 
behaviour theory suggesting the benefits of involving patients in their care (Bennett, 
2000) and corresponding, suppot1ive, clinical research (Fallowfield et al., 1994; Hack et 
al .. 2006; Keating et a/., 2006; Fischer et a/., 2006). The current study has shown 
patients in cancer settings have varied preferences for participation, in line with all 
previou studies, with a substantial proportion preferring a passive role. The research 
body has yet to answer the question as to whether supporting a patient to achieve their 
preferred role, or encouraging acti ve participati on, is more beneficial for improving 
psychosocial outcomes. Establishing this is vital to generate health care guidance, which 
wi ll lead to improved psychosocial outcomes for patients. 
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4.1.6. Section summary 
Distress is signi ficantly elevated at the time of decisions about treatment for cancer are 
made, and the current study has established that it is a significant factor to consider in 
understanding patient participation in decision-making. Higher levels of distress are 
associated with patients not achieving the level of participation that they would ideally 
pre fer in treatment decision-making. However, in line with theories of emotion 
regulati on, patients' ability to regulate their emotions moderates the association that 
distress has with their participation in treatment decision-making. However, the current 
study found no association between partic ipation in treatment decision-making and 
psychosocial outcomes. 
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4.2. Evaluation of study design 
ln order to evaluate the conclusions and clinical implications arising from the current 
rudy's findings, it is vitaJ to apprai e a design's strengths and weaknesses. Shapiro 
( 1996, p.202) states that "it is ... impossible to design the perfect study. The art of 
outcome research design thus becomes one of creati ve compromise based upon explicit 
understanding of the implications of the choices made". Barker eta/. (2002) recommend 
using Cook and Campbell' s (1979) framework to explore any imperfections, or threats to 
validity, of a study's design and the potential consequences of these. Although tailored 
for experimental, rather than observational studies, the framework is used below to 
evaluate the strengths and weakness of the current study systematically. Four types of 
validity are considered: internal val idity, external validity, construct validity and 
statistical conclusion vaJjdity. 
4.2.1. Internal validity 
Internal validity refers to the extent to which the design can answer the study hypotheses 
(Field & Hole, 2003). The current study's design was an alteration of some previous 
studies' methodology, in that it measured participant distress at the time of their 
consultation. This was a strength of the present design as it took account of the 
difficulties with retrospective design, such as unknown variables affecting participants 
recall or responses through the passage of time (Field & Hole, 2003). 
This choice in design, however, led to two specific compromises. Firstly, there was a 
potential experimenter effect; recruiting participants at the time of their consultation may 
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have altered their behaviour in the consultation. Secondly, the design required 
participant to complete a questionnaire at a time hypothe i ed to be stressful ; the mean 
core for the measure of distress, placed the sample in the clinical range. The response 
rate for the current study was lower than previous studie employing a retrospecti ve 
methodology, which may have been a consequence of the time in the treatment pathway 
that participants were recruited. The resulting small sample size has implicati ons f or 
statistical validity, discussed in section 4.2.4. 
In the current study's design, patients' preferences for participation and actual 
participation in treatment decision-making were only mea ured at one time point in their 
care pathway. As previously mentioned, one of the criticisms of previous research has 
been the use of a retrospective methodology to mea ure patient preferences for 
participation, especially as studies have shown that these preferences are not stable. A 
strength of the current study is that the prospecti ve de ign allowed valid and timely 
measurement of participant's perspecti ve. However, this cross-sectional measurement 
did not allow the current study to investigate whether the expressed preferences and 
perception of participation were stable and, centrally, whether the established 
relationship between distress and attaining a preferred role in decision-making persists at 
di f ferent points in a patient's care pathway. Establishing thi s would improve the internal 
validity of the current study·s findi ngs that distress is associated with patient's 
participation in treatment decision-making, and attainment of their preferred role. 
The study's main vari ables were measured using scales with established psychometric 
va lidity and reliability. However, in exploring the data, one patticular discrepancy was 
evident: the current sample had significantly tower scores on the Difficulties in Emotion 
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Regulation Scale compared to the normative data presented by Gratz and Roemer 
(2004). Tbis leads to the question of whether the current study provided a valid 
measurement of emotion regulation. There are several possible explanations for the 
lowered scores. Firstly, in the cun·ent study participants were approached dming a 
stressful time. It is possible that potential participants who did not participate, may have 
had poorer emotion regulation strategies. Secondly, there is an over-representation of 
women in the current sample; Gratz and Roemer (2004) found that women 's scores on 
the DERS were indicative of better emotion regulation; however this trend was only 
significant for one subscale. FinaJiy, it is acknowledged that the average age of the 
participants in the current study was older than the university student population with 
which the original psychometric analysis was carried out, and it could be hypothesised 
that emotion regulation strategies improve with age. Therefore, the demographic 
characteristics of the current study population may have led to lower scores on the 
Difficulties in Emotion Regulation Scale compared to tbe normative population. 
In answer therefore to the question of the validity of the scale's measurement in the 
current study, there are several hypothetical explanations for the observed discrepancy. 
Furthermore, although very little research has investigated how individual differences in 
emotion regulation affects health behaviour, research that has been carried out 
established similar findings to the current study (Collie et al. , 2005). Nevertheless, 
further research measuring emotion regulation and its impact on health behaviour would 
strengthen and provide further validation for the current study's findings. 
In any study, there may be extraneous variables that are unaccounted for, but heavily 
influence the variables of study. Consideration of the literature Jed to the conclusion that 
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considering patient participation in treatment decision-making as an expression of static 
demographic variables was severely limited. As such, it was suggested, in line with the 
current study's focus that research should focus on intra and interpersonal factors that 
may influence the process. The current study focused only on intrapersonal processes of 
distress and emotion regulation. The moderating influence of variables such as external 
sources of emotion regulation, the doctor's dominant consulting style or the complexity 
of the treatment decision to be discussed were not assessed. As such, they are suggested 
as areas for fu rther study, section 4.5. 
4.2.2. Construct validity 
Construct va lidity, often associated with the validity of individual measures, refers to 
whether a measured pattern of relationshjps is consistent with underlying theory. 
Certainly the findings of the current study are in line with decision theories, indicating 
that emotion is associated with disruption in planned decision-making processes. 
However, there are three limitations of the study in confirming the construct vaUdity of 
its find ings. First, the limited numbers in the study mean that analysis of causal 
relationships between the variables was not possible. Therefore, the study' s statistical 
analysis cannot lead to the conclusion that distress and poor emotion regulation are 
causal mechanisms in a person's ability to participate in decision-making. 
The second limitation is that the objective quality of decision-making was not measured. 
The measurement of participation in treatment decision-making was indexed by a self-
report tool. The decision preference statements have been widely used and similar to 
other tools, which use statements to measure decision-making. As they are self-report, 
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however, they index the perception of the patient only. Although in considering the 
psycho-social adjustment of the patient, it is their perception, which may be key, a self-
report measure may not provide a consistently valid index of shared decision-making, 
per se. 
The third limitation of the study is that it does not account for the mechani sm by which 
di stress may have been associated with participants not achieving their pre ferred level of 
participation, for example by disrupting information processing. The study was restricted 
to exploring the moderating effect of emotion regulation on the association. The study's 
findings are therefore limited in being able to account for this re lationship, and thereby 
unable to test the theory that people adapt their decision-making style with the goal of 
regulating their distress (Janis & Mann, 1977). 
4.2.3. External validity 
External validity refers to the extent to which the results can be generalised from the 
study setting (Barker et al. , 2002). The study fi ndings echo laboratory studies which 
have shown the impact that negative emotion is associated with disruption to decision-
making processes, however, the natural setti ng of the current study highlights the 
pote ntial rea l life effects. 
The tudy included people diagnosed with cancer, as opposed to other serious illness, at 
one point in the treatment pathway. Limitjng the sample to cancer care is important for 
the specificity of the study, as Arora and McHorney (2000) have established that 
diffe rent illness types lead to different pre ferences fo r participating in decision-making. 
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However, within cancer care, the inclusion criteria allowed recmitment from lung, 
breast, colorectal and gastrointestinal clinics. The care pathway for an individual patient 
depends on their route of referra l to the cancer services and the type and severity of 
cancer they were diagnosed with. Further, even within a care pathway for a specific 
cancer type, there is great variability as illustrated in Appendix 3 . This led to a 
heterogeneous sample. 
From one perspective, the heterogeneity of the current introduces more variables. The 
amount of information provided to the patient; the complexity of the treatment choices; 
or the number of treatment choices, may also be important to consider in further research 
aiming to understand how or whether patients attain their preferred role in decision-
making. 
Alternatively, it can be argued that the heteroge neity of the sample should increase the 
representativeness of a study population, and therefore the generalisability of its findings 
to the wider cancer population. However, the c urrent study's sample was substantially 
smaller than the majority of previous studies. The response rate (36.11 %) was lower 
also, and it was beyond the scope of the current study to establish if there were any 
socio-demographic differences, between those who participated, and those who 
refrained. Furthermore, several populations were over-represented such as females with 
breast cancer. In summary, therefore, there are real limitations in generalizing from this 
study; the study's findings would gain further external validity by being replicated in 
with a larger oncology population. 
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4.2.4. Statistical conclusion validity 
Stati tical conc lusion valjdity refers to the extent to which conc lusions based on 
stati tical analysis are sound. In assessing this, Barker et at. (2002, p. 230) ask three 
questions: a) was the study sufficiently sensiti ve to detect real effects in data? b) did the 
study find true statistica l relationships? and c) how meaningfu l were these relationships? 
In answering the first point, the number of partic ipants recruited was substantially below 
the number calculated as being required to detect real e ffects in the data. This placed the 
study at increased risk of Type 2 or ~-error that is missing an effect, which is in fact 
present. For the majority of the hypotheses. despite small numbers, significant effects 
were detected in the data. However. in evaluating the psychosocial outcomes, especially 
at three month follow up when the sample size was reduced by attrition, there is a 
possibility that accepting the null finding would be a Type 2 en·or. 
In answering the second point, the study found a number of statistically significant 
relationships using parametric tests. The data had previously been assessed as meeting 
the assumptions required for the validity of these tests. In additi on, when multiple 
analyses were made for post-hoc tests, a Bonferroni correction was applied to the a level 
required for statistical significance, to reduce the possibility of making Type 1 or a error, 
detecting a false positi ve effect. In sum, measures were taken to ensure the validity of the 
stati tical findings. 
The final consideration is the meaningfulness of the statistical relationships. Effect sizes 
calculated for hypotheses that were supported by significant findings showed that the 
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differences were indicative of medium to large effects. However, a note of caution must 
again come from the small sample size. Whi le the established effect sizes do indicate 
that the variables of study co-vary, the current study is limited in its ability to make 
conclusions about causality between the variables, or the influences of mediating 
variables due its lack of multivariate analysis. 
4.2.5. Section summary 
The strengths of the current study lie in its natural setting and real time assessment of 
variables. The most notable cause of weaknesses in the current study is the small sample 
size. Whi le the sample size proved sufficient to detect effects in the data, it has not 
a llowed multivariate analyses, to understand the causal relationships of variables; this 
reduces the confidence in generalizing the current fi ndings to the wider population. 
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4.3. Reconsidering the study of patient decision-making 
Patient participation in treatment decision-making continues to be focus for psychosocial 
research in cancer. Over the past twenty years, the focus has been on patient preferences 
for participation, as researchers debate the applicability of the wider health care system 
shift toward greater patient participation, to oncology popu lations. It is now heavily 
established that patients with cancer do not universall y want to be involved in treatment 
decisions, and despite the changing rhetoric of health care, this patte rn has not changed 
over time. This lies behind current guidance that patient participation in decision-making 
should be faci litated, if this is the patient's preference. 
However, considering preferences in isolation is insufficient, a the research has also 
established that a significant proportion of patients do not achieve the level of 
participation that they want. Very little research has investigated what influences the 
actual participation of patients in treatment decision-making, although the current study 
suggests distress is one contributory factor. Some studies have focused on demographic 
factors such as age and education, however, these are more likely to be covariates of 
more telling factors ranging from use of the media, to attitudes to health care to 
understanding of the disease. It is like ly to be a complex combination of intrapersonal, 
interpersona l and situational factors that will account for patients' participation. 
One of the weaknesses of the research at present is the lack of unifying theory from 
which to test assumptions about patient participation. The Theory of Planned Behaviour 
may provide a useful preliminary framework for understanding patient intentions or 
preferences fo r participation. However, while praised for its parsimony, basic criticisms 
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of this model, such as its inability to account for the influence of emotion and 
interpersonal processes, may li mit its utility to the field, and abi lity to account for actual 
participation. The Communication Model of Decision-making (Siminoff & Stepp, 2005) 
is more inc lusive of relevant factors, therefore providing a useful framework for guiding 
future research. The model, however. has been conceived inducti vely, from available 
research, and does not explain any compounding or co-varying relationships between the 
variables. The Decision Conflict Theory (Janis & Mann, 1977), alternatively, does 
suggests a specific process, which can be used to explain patient participation in 
treatment decision making. However, this model is limited to understanding stress in 
decision-making, and does not account for variables, which may contribute to this 
distre s such as illness characteristics, or ame liorate this stress, such as interpersonal 
processes. 
Therefore, perhaps a more powerful process model of patient participation in treatment 
decision-making is required, that can draw on decision theory and account for the all the 
mediating variables in the process of participation, akin to or in line with models 
developed to explain behaviour related to health. In order to do this, research will be 
required to establi sh further the central impeding and fac ilitating factors. The research, 
so far, has suffered some methodological limitations such as a focus on static 
demographic variables, retrospective methodologies, univariate analysis and over-
representations of specific patient populations. Nevertheless, its continued study is 
imperative, given the established association of psychosocial outcomes and participation 
in treatment decisions, albeit not shown by the current study. 
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4.4. Clinical implications 
Distress in cancer is elevated at diagnosis and can remain elevated throughout the course 
of the illness. The ubiquitous nature of distress in patients with cancer has led to the 
recommendation that psychologica1 assessment be carried out at key points in their 
progress through cancer services (NICE, 2002). The current study is just one illustration 
of the overlap that a person 's psychological needs can have with their medical care, and 
underlines the importance of assessing patients' emotional well-being. 
However, in practice, distress is often not identified, for example, an audit of a mental 
health service reported a referral rate of approximately 6% of the number of people 
diagno ed annually (Hallahan & Garland, 2004). Given that up to half of people 
diagnosed with cancer may experience clinically signi ticant emotional difficulties 
(Zabora er al., 200 I ), the authors queried whether this was due to poor detection of 
psychological morbidity. Therefore, explicit screening for elevated distress at key 
consultati ons may facilitate patient participation, treatment decision-making 
consultati ons being a case in point. 
The persistence of distress in cancer is partly attributable to the diagnosis initiating a 
catalogue of stresses, the focus of the current study being on the challenges faced at the 
time of making treatment decisions. Previous discussion ha highl ighted that although 
guidance strongly recommends that patients participate in deci ion to the extent they 
wish, there is little explicit guidance about how to facilitate this. The current study 
contributes to the small body of research beginning to uncover factors that may be 
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associated with the process of people achieving their prefe rred level of partic ipation, and 
as such supports the statement by Coulter et a/. (2008, p.3) that strategies to support 
patient partici pation should be a ·plank of health policy' . 
The current study has shown that distress is associated with people not achieving their 
preferred role in treatment decision-making. Theories suggest distress can interfere with 
cognitive processes, therefore strategies to support these, such as provision of plain 
language information or the use of decision aids will be useful in empowering patients to 
participate in treatment decision-making. A Cochrane review of 55 randomised 
contro lled trials of decision aids found that, compared to usua l care, decision aids led to 
greater knowledge; lower decision conflict; a reduced proportion of people feeling 
uninformed; and a reduced proportion of people passive in decision-making (O'Connor 
et a/., 2006). However, there are two specific issues: fi rstly, the uti lity of decision aids is 
unc lear, in that there is linle evidence they are being used in routine practice, and do not 
routinely appear as recommended by SIGN guidelines (SIGN, 2003, 2005a, 2005b, 
2006). The second issue is that they have not been found to improve psychosocial 
outcomes such as satisfaction with the decision-making; anxiety; or improved 
communication with health professionals (O 'Connor et al., 2006). Therefore, practical 
strategies such as decision-aids may only partl y ame liorate the detrimental effects of 
high levels of distress. 
The current study has suggested that emotion regulation processes may moderate the 
a ociation of distress with participation in treatment decision-making. Returning to the 
model of emotion regulation by Gross (2003), strategies to rein force patients' own 
emotion regulation strategies could be di vided into antecedent and response focused 
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strategies. In terms of antecedent focused strategies. information about what to expect at 
the clinic, sufficient staffi ng levels to allow ti mely appointment and initial contact with 
a person previously known to the person may all help to reduce distress for patients 
attending oncology c linics. In terms of response-focused strategies, intrapersonal and 
interpersonal processes can regulate emotion. The current study has focused on 
intrapersonal ability to regulate emotion, however, strategies to support patients' 
emotional well-being through intra-personal processes will also be valuable. NICE 
(2002) suggest that psychological support is the direct responsibility of all health and 
social care staff working with people with cancer. One of the key strategies by which 
health staff can provide emotion regulation is effective communication: communication 
for health professionals is now a core standard in the management of cancer services 
(NHS Quality Improvement Scotland, 2008). Communication training has been shown to 
lead to better recognition of distress; more empathy toward the patient; greater trust 
between the doctor and the patient; and better assessment of the interplay between the 
illnes and a person's psychosocia l c ircumstances (Klein , 1999, Moore et al., 2004). In 
the current context, the provision of specific training in the identification of distress and 
distress management for all people working at oncology c linic, including administration 
and aux iliary staff, may help ameliorate its potential impact at a key juncture of the care 
pathway. 
4.5. Areas of further study 
Although there is a copious amount of research looking at patient participation in 
treatment decision-making for cancer, few general trends have emerged so far. So far, 
the research body has focused on patient preferences, which has been useful to 
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understand the relevance of the theoretical and political shifts towards greater patient 
involvement in the clinical setting. However, there is significantly less research 
exploring what factors contribute to a patient's actual participation in treatment decision-
making, and more research in this area is required. 
The current study has introduced distress as a significant influencing variable to consider 
in future research, indicating that research needs to focus more in depth on the 
mechanisms by which distress is associated with participation in treatment decision-
making. This a lso needs to be investigated by methods alternative to cross-sectional 
surveyi ng, which has dominated the research body to date. It is also acknowledged that 
the current study focused on intrapersonal emotion regulation strategies only, however, 
interpersonal factors will also be important in ameliorating the impact of a person's 
distress, and as such require further in vestigation. 
Aside from patient distress, qualitative research and the Communication Model of 
Decision-making, described by Sirninoff and Stepp (2005), indicate there are many more 
influencing factors to investigate. Where previous research has been can·ied out into 
variables influencing participation in decision-making, there has often been a focus upon 
demographic variables such as age and education. The author would contend that 
continuing to place demographic variables at the centre of study might conceal other 
significant influencing variables, such as attitudes towards health care, which may co-
vary with demographic characteristics. 
The final area that requires further research, which is evident from the study find ings, is 
whether beneficial outcomes are brought by health professionals encouraging patients to 
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participate actively in treatment decisions, or enabling patients to participate to the 
degree that they wish. At present, the evidence is mixed and greater clarity is required to 
guide any further research into possible interventions. 
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5. CHAPTER FIVE: CONCLUSION 
The current study explored the relationship between patient distre s and participation in 
treatment decisions for cancer. Often decisions about cancer treatments invol ve complex 
information and have to be made when the person is adjusting to difficult news; 
however, patients are increasingl y being expected to be acti ve partners with health care 
professionals in making decisions about their treatment. The current preferred model of 
treatment decision-making is shared decision-making, whereby the doctor and the patient 
are equal partners. Research, including the current study, has shown that patients, in fact, 
have mixed preferences for their level of involvement in making treatment decisions. 
A lthough current guidance states that patients are entitled to participate, should they so 
wish, in keeping with previous studies. the current rudy ha shown that a proportion of 
patients are not achieving their preferred role in treatment decision-making. Previous 
research has focused on demographic variables that may influence the role patients take 
in treatment decision-making, however, less attention has been paid to contextual 
factors. The current stlldy found that higher levels of distress were associated with a 
greater proporti on of patients taking a passi ve or acti ve role, as compared to sharing the 
decisions. Furthermore, higher level s of distress were associated with patients not taki.ng 
the role in decision-making, that they stated they preferred. 
Emotion regulation is the mechanism by which people modi fy their emotions in order to 
achieve a goal. The current study found that greater difficulties with emoti on regulation 
was associated with patients not taking the role in decision-making. that they stated they 
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preferred. Individual differences in the abili ty to regulate emotions may moderate the 
in fluence of distress on the treatment decision-making proce s. 
One of the moti vations for encouraging patient participation in treatment decision-
making has been research showing it can lead to improved pati ent outcomes, particularly 
for psychosocial variables such as psychological adjustment to illness and satisfaction 
with the decision made. There is also some research that rather than a more active role, 
taking a preferred role in treatment decision-making leads to improved outcomes. The 
current study did not find any evidence for this, with no di fference in psychosocial 
outcomes between participants whose role in decision-making was concordant with their 
preference, and those whose role was not concordant. De pite the lack of evidence from 
the current study, resolving the conundrum, of whether enabling patients to participate in 
decision-making to the degree they wish. or acti vely encouraging participation leads to 
better outcomes, should be central to further research. 
To conclude, distress is significantly associated with pati ent involvement in treatment 
decision-making. In particular, it is associated with patients not taking the role in 
decision-making they prefer. Given that current policy indicates that patients should be 
acti ve partners in their health care, and enabled to participate in decision-making if they 
wish, this finding is of note. Specific attention should be paid to patients' emotional 
well-being, particularly at key junctions of the care path way. to en ure patients' 
p ychological needs are met and to avoid detrimental consequence for thei r health care. 
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Me thod and instrument Summary of S ummary of Associations with patient preference investigated 
Refere nce 
used to measure Participants and preferred roles actual roles in ./ =significant x = not si1!0ificanl 
decision-making response rate in decision- decision-
Age Education Sex 
E motional Othe r sig. I 
preference making making well-being associations i 
Barry & Semi-structured interviews; 7 palliative cancer 
Disease 
I 
Henderson Control Preferences patients; likely to be - - - - - - progression* 
(1996) (Degner & Sloan. 1992) terminal in 6 months I 
Beaver & Cross-sectional; structured 53 gynaecological 20.8% Active; 22.7% Active; 
I 
Booth (2007) interview; Control cancer patients; 24-82 32. I% Shared; 18.9% Shared; 
JC . - - -Preferences (Degner years; average 16 weeks 47.2% Passive 58.5% Passive 
&Sloan. 1992) since diagnosis 
.Beaver et al. Cross-sectional survey; 150 female breast 20% Active 15.3% Active i 
(1996) Control Preferences cancer patients; newly 28% Shared 24.0% Shared; ./ ./ - - Social class 
(Degner & Sloan, 1992) diagnosed 52% Passive 60.7% Passive 
nlanchard et Mixed methodology: 439 cancer inpatients 69% preferred to Prognosis 
a/. (1988) observational study participate Physical well-
combined with survey; 3 I % prefcned to - ./ - ./ -
Instrument adapted from leave decision 
being 
Cassileth et al. (1980) up to doctor 
Cancer type 
Bruera et aL Cross-sectional survey; 57 female breast cancer 22.8% active; Previous 
(2002) Questionnaire based on at diagnosis; 79% 66.7 shared - X X - . 
Degner eta/. ( 1997) response rate 10.5% passive 
treatment 
Butow et al. Cross-sectional survey; 20 males and 60 female 22.6% active; First 
(1997) Decision preferences cancer patients; 89.9% 36.3% shared; consultation 
statements (Sutherland et response rate; 18-87 41.3% passive - X - ./ - Religious 
a/. 1989) years locus of 
control 
Davison & Randomised Controlled 60 male prostate cancer 25% active; 
Degner Trial; Control Preferences patients; 43.3% shared; - X X - - -
(1997) (Degner &Sloan, 1992) 31.7% pass ive 
Table 14: Summary of quantitative s tudies looking at factors associated with patient prefere nces for participation; *only descriptive statistics reported 
169 
Method a nd Summary of Sununary of Associations with patient preference investigated 
Reference 
instrument used to Participants and preferred roles achtal roles in ./ = significant x = not significant 
measure decision- response rate in decision- decision- Emotional Other sig. 
making preference making making Age Education Sex well-being associations 
Davison et Cross-sectional survey 87 male prostate cancer 42.5% active; 
a/. (2004) Control Preferences patients: 87% response 47. 1% shared; 
)C • (Degner & Sloan. 1992) rate. 46-84 years; at 11 .4% passi vc - - - -
time of diagnosis 
Degner & Cross-sectional survey: 209 female and 227 12% active; 
Sloan Own instrument male cancer patients; 29% shared; ./ ./ ./ 
(1992) average 75 days post 59% passive - - -
diagnosis 
Degner et Cross-sectional survey: 101 2 female breast 22% acti ve, 
a/. (1997) Control Preferences cancer patients; 4 days 44% shared Previous experien:;~ 
(Degner & Sloan. 1992) to 32.4 years post- 34% passive - ./ ./ - - Time since 
diagnosis; 85% diagnosis 
reSQ<>OSe rate 
Elkin eta/. Cross-sectional; 73 cancer patients over 25% active; 
(2007) structured interviews: 70 years old; wi thin I 6 23% shared: 
)C • )C Control Preferences weeks of metastatic 52% passive - - -
(Degner & Sloan. 1992) diagnosis 
Hack & Cross sectional 70 female breast cancer 25.7% active: 
Degner structured interview patients 1.5-6 months 48.6% shared; 
(1999) Cluster Analysis post diagnosis 25.7% passive - - - - ./ -
Control Preferences 
(Degner & Sloan. 1992) 
Hack et al. Mixed design: cross- 35 female breast cancer 22.9% active; Desire for 
(1994) sectional survey and patients; 32-82 years; 2- 57. 1% shared; information about 
semi-structured 6 months post diagnosis 20% passive - )C ./ - - diagnosis and 
interviews; Card Sort treatment 
(Degner & Sloan. 1992)) procedures 
Table 14 (continued): Summary of quantitative studies looking at factors associated with patient preferences for participation 
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Method and Summary of Summary of Associations with patient preference investigated 
Reference 
instrument used to Participants a nd preferred roles actual roles in ./ = significant x = not significant 
measure decision- response rate in decision- decision-
Age Education Sex 
E motional Other sig. 
making preference making making well-being associations 
Jansen, eta/. Cross-section a I; 446 cancer patients; 62% 18.7% active; Per<.:eption of 
(2006) survey; Decision response rate; 32-89 years 34.5% shared; treatment 
preference statementS 29.6% passive - - - - - choice 
(Sutherland et at. 
1989) 
.Janz et al. Cross-sectional; 101 female breast cancer 39.4% active; 61.7% active; 
(2004) struclllred interviews patients prior to treatment 47.5% shared; 30.3% shared; 
Control Preferences decision meeting 13. 1% passive 8.1 % passive X ../ - X -
(Degner & Sloan, 
1992) 
Kractschmar Cross-sectional survey; 606 female breast cancer. 2.9% acti ve; Perceived 
et at. (2004) Problem Solving prostate cancer and 67.3% shared; knowledge of 
Decision-mak.i ng Scale frac/llre patients; various 29.7% passive - - - - - condition 
(Deber et a/. 1996) stages of disease; 99% Trust in 
response rate physician 
Lam eta/. Cross-sectional survey; 154 fema le breast cancer 33. 1% active 
(2003) Researcher's own patients; 28-79 years; I to 59. I% shared 
" X - - - -measure lO months post diagnosis; 7 .8% passive 
89.5% response rate 
wbbetaL Cross-sectional survey; I 00 female breast cancer 23% active 
(2001) Likert scale based on patients; within 2 months 54% shared 
Control Preferences of diagnosis 23% active - ../ X X - -
(Degner & Sloan, 
1992) 
Onget al. Cross-sectional survey; I 02 fema le and 2 1 male 15.8% active 
(1999) Decision preference cancer patiems; 51.6% shared ../ 
statements (Sutherland 19.6% passive - - - - -
et a/. 1989) 
Table 14 (continued): Summary of quantitative studies looking a t factors associated with patient preferences for participation 
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Method and Summary of Summary of Associations with patient preference investigated 
instrument used to Participants and actual roles in ./ = significant x = not significant Reference 
measure decision- response rate 
preferred roles in 
decision- Emotional Other sig. 
making preference 
decision-making 
making Age Education Sex well-being associations 
Petrisck et at. Cross-sectional 179 female breast 5% would have 
(1997) survey: Researcher's cancer patients; 3 to 12 liked someone to ./ - - - - -own measure months post diagnosis; make the decision 
78.9% response rate 
Ramfclt et al. Cross sectional; 85 newly diagnosed 5.9% active; 7 .1 % active; 
(2000) sLructured interviews; colorectal patients; 62.4% shared; 16.4% shared; 
Control Preferences 47.6% male. 52.3% 31.7% passive 76.5% passive lC )C lC - -
(Degner & Sloan, female; 
1992) 87.6% response rate 
Ramfclt et at. Cross sectional: 55 colorectal patients I 1.8% active; 
(2005) structured interviews; year post diagnosis 74.5% shared; 
Control Pre ferences 2 1.8% passive - ./ ./ - - . 
(Degner &Sloan, 
1992) 
Rothenbacher Cross sectional; 59 advanced cancer Patients with Occupalion 
et al. (1997) structured interviews; patients; 86 non cancer: 
Control Preferences malignant paUiative 9% active - ./ ./ lC -
(Degner &S loan. care patients; I 15 non- 73% shared 
1992) hospitalised patients 18% passive 
Sainio & Lauri Cross-sectional 273 cancer patients ; 2 3 1% not at all 7% made Physical 
(2003) survey; Own months to 15 years post important to make decisions condition 
instrument diagnosis: 90% own decisions; themselves; 70% lC lC ./ lC 
response rate 72% important to shared decision 
share decisions to some extent 
Salkeld et at. Cross-sectional I 02 male and 73 female 15.4% active; Patient has 
(2004) survey; colorectal cancer 28.6% shared; received 
Questionnaire based patients; 6 months to 2 53.7% passive - ./ lC ./ - radiotherapy 
on Degner et al. years post surgery; 
( 1<)9_ZL_ ______ 80% response rate 
Table 14 (continued): Summary of quantitative studies looking at factors associated with patient preferenc:!s for participation 
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Method and Summary of Summary of 
Associations with patient preference investigated 
./ = si~nificant " = not si~ificant 
Reference 
instrument used to Participants and preferred roles actual roles in 
Emotional 
measure decision- r esponse rate in decision- decision-
Age Education Sex Well-
Other sig. 
making preference making making 
be in~ 
associations 
Stewart et al. Cross-sectional survey; 105 ovarian cancer pati ent~; Diagnosis: Condition 
(2000) Instrument designed 2 1-87 years; 75.5% response 14.3% acti ve perceived as 
based on Cassileth e1 rate 62.9% shared serious 
al. ( 1980) and Degner 22.9% passive Metastases 
el a/. ( 1997) Treatment: present 
17.3% acti ve 
59.6% shared - JC - • . . 
2 1.9% passive 
After treatment: 
15.2% active 
61 . 9% shared I 
2 1.9% passive 
Stiggelbout Cross-sectional survey; 55 cancer patients (9 1.2% For cancer Being a current • 
& Kiebert Decision preferences response rate), 53 people patients: patient 
(1997) statements (Sutherland accompanying them, 53 13.5% active; - ./ . ./ -
e1 a/. 1989) smgical patients, 36 people 25.0% shared; 
accompanying them; 6 1.5% passive 
Sutherland et Cross-sectional survey; 35 female and 17 male 9 .6% acti ve Information 
al. (1989) own instrument cancer patients 26.9% shared; - - - . . seeking 
63.5% passive behaviour 
Vogel et al. Cross-sectional ; 137 female breast cancer 30.6% active; 35.8% active; Perception of 
(2008) Control Pre ferences patients following treatment 29.2% shared; 12.7% shared; ./ treatment 
(Degner &Sloan, 1992) decision meeting; 19-75 40.2% passive 51.5% passive 
. - . choice 
years 
Table 14 (con tinued ): S ummar y of quantitative studies looking at factors associated with patient preferences for participation 
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Method a nd inst rument Summary of Summ ary of Associations with patient preference investigated 
Refer ence used to measure decision-
Par t icipants and preferred roles actual roles in -/ = significant x = not s ignifi cant 
making prefe rence 
response ra te in decision- decis ion-
Age Education Sex 
Emotional Other s ig. 
making making well-being associa tions 
Wall berg et Cross-sectional survey: 20 I female breast cancer 16% active 
a/. (2000) Control Preference~ (Degner patients; immediately prior 18o/r shared 
& Sloan. 1992) or following treatment 66% passive - ""* ./if. - - -decision-making: 77% 
response rate 
Wong eta/. Cross-sectional 101 male prostate cancer 11 -2 1% act ive; 
(2000) questionnaire survey; patients; 63.5% response >60% shared; 
instrument designed past rate 13-25% passive 
X X )t 
research including Cassi leth - - . 
et at. ( 198); Degner and 
Sloan ( 1992) 









Validity Key findings 
ra te 
Charles et Open ended, in 20 female Independent • Most preferred shared decision-making; a few preferred a passive role . 
aL (1998) depth personal breast cancer review of • Doctors seen as the 'experts' and treatment decisions as requiring expertise, knowledge and interviews; patients; 42-78 analysis by 
clinical experience. Some respondents felt that they should therefore be passive. 
Thematic codi ng years experienced 
using computer researcher; • There is a reluctance to question doctors for fear of appearing distrustful or losing confidence 
programme audit trail: in the decision. 
NUD*IST presentation of • Participating in treatment decision can provide a feeling of control. 
representative • Women viewed that decision-making could be ' right' or ·wrong· and the 'decision-maker' 
quotes may be responsible for this. 
Cohen and Semi-structured 19 male tndependent • Difficult to concentrate on decision-making due to distress of diagnosis in same consultation . 
Britten interviews; prostate cancer thematic • A directive role welcomed, as the decision was seen to require expertise (2003) Thematic analysis patients: 58-88 analysis by 2 
• Trust can be placed in the professional. using computer years researchers 
programme ATLAS • Some men anxious about assuming responsibil ity for the outcome . 
• Some wanted to be viewed as a 'good patient' and felt being more active or questioning may 
be disrespectful. 
Elit e/ a/. In-depth, semi- 2'1 female Independent • Most wanted to be involved in the treatment decision-making . 
(2003) structured ovarian cancer thematic • Knowledge is necessary for the treatment decision . in terviews; thematic patients; 47-77 analysis by 2 
• Trust was put in the doctor's expert.ise . coding using years researchers 
computer • Post-operative procedure overwhelming; difficulty concentrating at the time the treatment 
programme NYivo decision was made. 
• Some felt frightened and pressured into a treatment decision . 





Ke> findings Reference and analysis 
and r esponse 
Validity 
rate 
Hack etal. Semi-structured 35 female Not discussed • Desire tc be ~:ept informed of the treatmert p· an in spite of role 
(1994) interviews; Content breast cancer • Important to place faith and trust in doctors b:!cause of their :!Xpertise . analysis patients; 32-82 
• Some passive patients describec that pe5sure to be more aclive in decis i)n-making '.Nas years; 2-6 post 
diagnosis anxiety-provoking. 
• Reasons for assuming a passiv~ role includEd mental in:innit}, lac< of education. and 
difficulty accepting the cancer diagnosis. 
• Other factors that influenced the preferen::e •) f an active or passivt:. roE included faith in the 
physician, wi Ito live, and general coping style ·n response t:· threaleni:t.=: situc.tions. 
Henman el Semi-structured 20 female Author • Half of the sample wanted tO make decisic•nS wi:h their docto~s . 
al. (2002) te lephone cancer patients consensus, • Four themes emerged as to what .vas fe lL w be critical in reaching U1e ri §:ht d~ision: dcctor's interviews; 2-4 weeks post presentation of specialist knowledge; feeling listened to: fEeling included in :he dccisioa-makirg proce;s :md 
Thematic coding diagnosis represemati ve 
trust and confidence. 
using computer quotes 
programme 
NUO*IST 
Husain et In depth qualitative 2 1 female lndependent • Many remained silent in front of medical tean 
al. (2008) interviews; breast cancer analysis by 2 • Main approach to decision-making was to rely heavily on advice and cpinioo of healn care Framework analysis patients; over researchers 
team. Factors affecting role in decision-making included truM in doctt·r. rc:lia1ce on deoctor's 
76-9 1 years; 
expe11ise and previous personal experiencef. cf cancer. 
70% response 
ra te 
Kenny el Semi-structured 40 female Independent • Respondents differed in preference for partici ;:>alion . 
al. (1999) interviews; content breast cancer coding and • A passive role was associated wit:1 lack of medical knowledge and o:pertise, placing trust and and thematic patients; l year anal ysis by 2 faith in doctors and anxiety about making :he 'wrong' decision as intluen::ing fa.::tors. 
anal ysis post treatment researchers 
Amore active role was associated with ft:ehng that they sh: uld rake -esponsibility f01 :heir • 
own bodies, and reco~nisin~ that.joctors cculd be fallible. 










Sainio et aL Focused interviews; 18 male and 16 Use of • Patient factors which promoted participation were good health, adequate information. ability 
(2001) content analysis female cancer software, to confront situations, personality, assertiveness, social support. 
using computer patients; at least parallel • Patient factors which limited participation were poor phySical and mental health, lack of programme ATLAS 2 months post analysis by knowledge, fear and age. 
diagnosis researchers 
Sanders & Semi-structured 24 male and 13 Not discussed • Many informants felt that decision was no! their responsibility because they were not the 
Skevington interviews and female expert. 
(2003) observation; Coding colorectal • Some informants did not want to participate for fear of finding out anxiety provoking according to cancer patients 
information. 
Grounded theory 
• Most patients did not perceive that there was a choice to make . 
Table IS (continued): Summary of qualitative studies exploring factors affecting patient preferences for participation 
l77 
Method and Summary of Associations with actuaJ patient role 
Reference instrument used to Participants and preferred 
Summa ry of actual ./ = significant x = not significant 
me.asure decision- r esponse rate roles in 
roles in decision-
E motionaJ O ther sig. 
decision- making Ago: Education Sex making role 
making 
well-being associa tions 
Bilodeau & Cross-sectional survey; 74 women with breast 20% active 19% active 
Degner Scale based on Degner cancer 37% shared 24% shared ./ - - - -
(1996) and Sloan ( 1992) 43% passive 57% passive 
Fischer et Longitudinal survey; 126 prostate cancer 18% active X 
• Known stage aL (2006) Scale based on Degner patients; various - 60% shared ./ - . (coping of disease 
and Sloan ( 1992) stages of illness 22% passive style) 
Hawleyet Cross-sectional survey; I 038 breast cancer 39% active • Treatment 
al. (2007) Scale based on Degner patients; 270 surgeons - 38% shared X - . . options 
and Sloan ( 1992) 22% passive discussed 
L iang eta/. Cross-sectional survey; 61 3 breast cancer • Physician 
(2002) Perceived Partic ipation patients paired with training 
in Care Scale (Lerman their surgeons • Treatment . - X - . -et at. , 1990) options 
ide01ified 
• Social support 
Maly et al. Cross-sectional survey; 222 breast cancer 53.2% self as final • Emotional 
(2004) Own statements patients; over 55 decision maker; support 
years; average 7.1 36.9% doctor as 
X 
• Direct 
months s ince 
. 
final decision maker - . - invitation for 
diagnosis 10.0% other as final participation 
decision maker • Self-efficacy 
Peterson et Cross-sectional survey; 79 cancer patients; 33% Information 
aL (2003) Own instrument waiting for treatment seeking 
to start 23% fnformation 
X . 





Table 16: Summary of quantitative studies investigating factors affecting patients' actual particip ation in decision-making 
Method and Summary of Associations with actual patient role 
Reference ins trument used Participants a nd preferred roles 
Summary of actual "' = significant x = not si :nificant 
to measure response rate in decision-
roles in dec.ision-
Emotional Other sig. decision-making making Age Education Sex 
r ole 
making well-being associations 
Pinquhart Cross-sectional 140 cancer • Cognitive 
et al. (2004) survey; Own patients; 57% abilities 
instrument male; 18-83 years; - - .., .., X X • Belief in 
I week post- powerful others 
diagnosis 
Sainio & Cross-sectional 273 cancer 31 % not at all 7% made decis ions • Physical 
La uri survey; Own patients; 2 months important to themselves; 70% condition 
(2003) instrument to IS years post make own shared decision at 
X X 
• Marital status 
X X 
diagnosis; 90% decisions; 72% least to some extent 
response rate important to 
share decisions 
Siminoff & Observational I 00 breast cancer 80% accepted • Knowledge 
Fetting Study & semi- patients; at - physicians primary - .., - - • Strength of (1991) structured oncology decision- treatment physician 
interview making meeting recommendation recommendation 
Street & Observational 62 initial One fifth of utterances • Length of 
Gordon study; behavioural consultations for by lung cancer patient appointment 
(2006) coding of audio- lung cancer and 88 - indicative of active - - - - • Physician 
transcripts post-angiogram participation facil itation 
consultations • Elhnicity 




Retia bili ty I 
Reference 
and a nalysis 
and response 
Validity Key fmdings 
rate 
McVeaet Semi-structured 25 women 1.8 Independent • More than half of participants played a passive role in decision-making . 
al. (2001) interviews and years post coding • Perceiving a choice was determi.ned by medical factors or doctor offering choice . thematic analysis diagnosis on analysis by 
average breast three • Intense emotional distress affected decision-making ability . 
cancer researchers • Participants who did engage in a rational decision-making process based choices on 
concerns about body image and fear of recurrence. 
• Adjustment to the diagnosis made it difficult for them to understand or remember 
information about treatment options. 
Table 17: Summary of qualitative studies investigating factors affecting patients' actual participation in decision-making 
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Appendix Three: Patient pathways for each cancer type with oncology consultation 
highlighted 
Patient Pathway Lung Cancer 
GP referral Referral from other specialist 
~ One-stop tug clinic .------
CNS~ 1 
Investigations- clinical exam. CT scanning, bronchoscopy, + spirometry 
Patien~ given provisonal findings and follow up opd within 1/52 
.--------- Results correlated & discussed in MDT. 
Futher investigations i: I ~ Complex cases + ~ Discussed at 
If diagnosis not confirmed Edinburgh mdt 1/7 
video assisted thoroscopy after DGRI MDT 
Endoscopic ultJ·asound btops 
Surgery 
.------------ ~  
Radiotherapy Chemotherapy 
Review as determined by individual needs 
Referral to other 
disciplines * 
Best supportive care 
* Appliance, District Nurse, Dietician, Macmillan, Occupational Therapy, Palliative Services, 
Physiotherapy, Social Work. 
6 
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Patient Pathway - Breast Cancer 
GP referral Sel.f-referral Referral from other specialist 
~ One-stop treast cUni~ 
CNS~ l 
CNS involved in support, 
Information giving etc 





. ~. . . tagmg mvesnganons 




l ~CNS liaises with consultants, X-ray, /CUnical aumt, pathology and secretaries 
MDM/combined clinjc 
Clinical trial and Research Nurse 
may become involved 
Hormone treatment 
CNS bas close involvem~ Surgery Radiotherapy Chemotherapy...,_ CNS organjses and 
with ward 6 ------ . (may be rmbination of all 3) supervises chemo 
Continuous contact by CNS with patient, family & WGH 
throughout treatment 
CNS remains contact for 
patients through through all 
follow-up and any treatment 
for disease recurrence 
Surgical long-term follow up (10 years) Oncology long-term follow-up 
Involvement of CNS 
Other releva nt disciplines 
Eg Dietitians, SLT, Physio, DIN, Macmillan nurse 
Social work, Palliative care team may be referred to at any time by CNS 
8 
183 
Colorectal Cancer Patient Pathway 
Elective 
GP Referral Other Specialities 
-------- ____.--a;;;troenterologist, Physician 
------. Colorec;l Surgeon .---- - -- Radiologist 
OPD 
Flexible Sigmoidoscopy & Biopsy 
• •• Registered witb Audit +------- D•agnos•s made 
Discussed at multi -disciplinary meetings Consultant discusses 
until completion of treatment Diagnosis a~ Treatments 
Staging CNS 
T 
Bloods, Chest x-ray. Ba Enema!Coloooscopy 
Liver Ultrasound for Ca Colon or Rectum 
(3) 
Neo-adjuvant 
Colorectal Nurse Specialist 





Referral to Palliative 
Care Team 
CNS 
Surgical Ward or both 
Surgery moiherapy or Radiotherapy 
HDU{ITU .,.-




~ t Discharged 
Stomas 
Involvement of a mixture of the following: 
Colorcctal Nurse Specialist, 
Stoma Care Nurse, Ward Staff, Physio, OT, 
Palliative Care Team, Social Services, 
Temporar1Loop 
CNS :::..,,;:;;==::::l::iitllir.!£!~urse, Peripheral Hospitals, Care 1-lomes 
Follow Up 
Surgeon (5 years) 
Colorecta l Nurse Specialist 
Stoma Care Nurse Adjuvant 
\ tr~~~tenr llr~at;tent 
7" '""--------------. ~. ,, Oncologist CNS --._ 
Liver ~etastascs 
Ref:flto Ed~gh Royal 












Chemothe.rapy or Radiotherapy 
or bo th 
CNS 
10 
Pall iative Care 





Oesophageal and Gastric Cancer 
G.P. Referral to 
Surgeon/Gastroenterologist 
l 





./ C.N.S. Non-Candidate for 
~ ! Resection 






Endoscopic Ultrasound Scan 















Palliative Care Team 
Firs t contact at Endoscopy or Oiagnosis and continued input throughout patient journey 
12 
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Appendix Four: Participant information (reformatted) 
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Patient Involvement in Treatment Decisions 
Information about the research: For Potential Participants 
The Department of Psychological Services and Research would like to invite you to take 
part in a research study. 
Before you decide, please take the time to read the following information carefully. Feel free 
to ask us if there is anythjng that is not clear or if you would like more information. 
What is the research about? 
The research study is lookjng at patients' views on their involvement in decisions about their 
treatment for cancer and how people cope with their emotions at this time. We are also 
interested in whether being involved in treatment making decisions affects how people 
adj ust to having cancer. The research will help us learn more about how patients would like 
to make decisions about their treatment as well as what may affect this. In the future, this 
will help us to make this process easier for patients. 
What does it involve? 
At your next clinic appointment, a researcher will speak with you. She will ask you if you 
have decided to take part. If you agree to participate, you will be given a short questionnaire 
to fill in before your consultation with the doctor. 
You will also be given a questionnaire to complete in your own time. You can return these 
questionnaires in the stamped addressed envelope, directly to the researcher or to the 
reception desk at the Macmill an Centre. 
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The first questionnaire asks about your preferences for participating in decision making 
about your health care as we11 as your emotions at this time. This should take you about 5-10 
minutes. 
The second questionnaire (the one you take home with you) asks about how you felt your 
consultation went, as well as questions about coping at difficult times and with your i11ness. 
In total this should only take you about 15-25 minutes. 
In 3 months time, we wi11 send you a further questionnaire to complete by post. This wi11 
again ask how you are coping with your illness. This will only take about 10- 15 minutes. 
Again you will be able to return it in a stamped addressed envelope, directly to the 
researcher or to the main reception desk at the Macmillan Centre. 
If you would like further information about the questionnaires or what is involved, please 
contact Frances Scrutton on 
Deciding to take part 
It is up to you to decide whether to take part in this study. We genuinely value your opinion 
and the more people who contribute, the more meaningful the results will be. We intend to 
use the findings of this research to shape future services to support people with cancer and 
their families. 
At your next clinic appointment, the researcher will ask you if you have decided to take part. 
At this time, she will ask you to sign a consent form to show you have agreed to take part 
and give you the questionnaires. Once we have received all your questionnaires, your 
answers will be separated from your consent form and your responses wi11 be anonymous 
and confidential 
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Your Consultant, Clinical Nurse Special ist and G.P. wi ll NOT be infom1ed of your 
responses. Only if we have concern regarding your safety or that of another will information 
be passed on. In thi s case, you would be contacted by the researcher to discuss in more detail 
the concerns you have raised. 
IF YOU DO NOT WISH TO BE APPROACHED BY THE RESEARCHE R TO ASK 
IF YOU WOULD LIKE TO PARTICIPATE PLEASE LET YOUR NURSE OR THE 
SECRETARY KNOW ON THE CLINIC DAY 
If you do decide to take part, thi s will not affect your access to services in the future from 
NHS Dumfries and Galloway. Also, please note that you can withdraw from the project at 
any time, without g iv ing a reason. 
How will I find out the results of the research? 
All the replies will be collated and a report will be written summari si ng everyone's thoughts. 
This report will be available to you in autumn 2009. In addition, you will receive an 
in vitation to an evening wh ich will be held to present the findings of the research and to 
address any questions. 
All research in the NHS is looked at by an independent group of people, ca11ed the Research 
Ethics Committee to protect your safety, rights and we11being. 
NHS Dumfries and Galloway R esearch Ethics Committee have reviewed this study. 
However, if you have a concern about any aspects of thi s study, please speak to researchers 
who will do their best to answer you questions. 




For further information, please contact researcher 
FRANCES SCRUTTON 





For independent advice, please contact Gwen Baxter, NBS Dumfries and Galloway 
Research and Development, Dumfries and Galloway Royal Infirmary, 
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Normal P-P Plot of Emotion Regulation 
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Figure 13: P-P plot and histogram for emotion regulation measured by DERS 
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Normal P-P Plot of Psychological Adjustment 
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Psychological Adjustment 
Figure 14: P-P plot and histogram for psychological adjustment measured by 
Fighting Spirit/ Helpless-hopeless Subscale 
194 
Normal P-P Plot of Psychological Adjustment - Follow up 
0 .0 0.2 0.4 0.6 0.8 1.0 
Observed Cum Prob 
20.00 40.00 60.00 
Psychological adjustment at follow up 
Figure 15: P-P plot and histogram for psychological adjustment measured by 
FS/H-H subscale at three month foUow up 
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Figure 16: P-P plot and histogram for satisfaction with decision measured by 
Satisfaction with Decision Scale 
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Normal P-P Plot of Satisfaction with Decision - Follow up 
0.0 0.2 0 .4 0 .6 0 .8 1.0 
Observed Cum Prob 
20 22 24 26 28 30 
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Figure 17: P-P plot and histogram for satisfaction with decision measured by 
Satisfaction with Decision Scale at three month follow-up 
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Levene dfi df2 Sig. Statistic 
Distress Based on Mean 
.142 I 1 1 .713 
Based on Median 
.139 1 L 1 .716 
Based on Median and 
.139 with adjusted df L 10.133 .717 
Based on trimmed mean 
.146 l ll .710 
Emotion Based on Mean 
1.895 I I I .196 Regulation 
Based on Median 
1.833 1 11 .203 
Based on Median and 
1.833 with adjusted df I 10.995 .203 
Based on trimmed mean 
1.907 1 11 .195 
Psychological Based on Mean 
.648 .438 Adjustment I 11 
Based on Median 
.561 I 11 .470 
Based on Median and 
.561 I 10.975 .470 with adjusted df 
Based on trimmed mean 
.651 I 11 .437 
Psychological Based on Mean 
.234 .638 Adjustment at l 11 
follow up Based on Median 
.413 I II .534 
Based on Median and 
.413 I 9.464 .536 with adjusted df 
Based on ttimmed mean 
.235 I L I .638 
Table 18: Table showing Levene's test for homogeneity of variance between groups of participants 
based on matched or unmatched roles. Continued overleaf. 
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Levene dfi dt'2 Sig. Statistic 
Satisfaction with Based on Mean 
.100 .758 Decision 1 ll 
Based on Median 
.122 l 11 .734 
Based on Median and 
. 122 with adjusted df 1 9.253 .735 
Based on trimmed mean 
.109 l 1 L .748 
Satisfaction with Based on Mean 
.003 decision at follow I II .958 
up Based on Median 
.016 I 11 .903 
Based on Median and 
.016 I 9.1 59 .903 with adjusted df 
Based on trimmed mean 
.004 I II .951 
Table 18 (continued): Table showing Levene's test for homogeneity of variance between groups of 
participants based on matched or unmatched roles 
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